#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Altered anterior cingulate cortex to hippocampus effective connectivity in response to drug cues in men with cocaine use disorder Drug-related attentional bias may have significant implications for the treatment of cocaine use disorder (CocUD).
1-1	0-7	Altered	_
1-2	8-16	anterior	_
1-3	17-26	cingulate	_
1-4	27-33	cortex	_
1-5	34-36	to	_
1-6	37-48	hippocampus	_
1-7	49-58	effective	_
1-8	59-71	connectivity	_
1-9	72-74	in	_
1-10	75-83	response	_
1-11	84-86	to	_
1-12	87-91	drug	_
1-13	92-96	cues	_
1-14	97-99	in	_
1-15	100-103	men	http://maven.renci.org/NeuroBridge/neurobridge#SubjectwithoutDisorder
1-16	104-108	with	http://maven.renci.org/NeuroBridge/neurobridge#SubjectwithoutDisorder
1-17	109-116	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
1-18	117-120	use	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
1-19	121-129	disorder	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
1-20	130-142	Drug-related	_
1-21	143-154	attentional	_
1-22	155-159	bias	_
1-23	160-163	may	_
1-24	164-168	have	_
1-25	169-180	significant	_
1-26	181-193	implications	_
1-27	194-197	for	_
1-28	198-201	the	_
1-29	202-211	treatment	_
1-30	212-214	of	_
1-31	215-222	cocaine	http://maven.renci.org/NeuroBridge/neurobridge#CognitiveDisorder
1-32	223-226	use	http://maven.renci.org/NeuroBridge/neurobridge#CognitiveDisorder
1-33	227-235	disorder	http://maven.renci.org/NeuroBridge/neurobridge#CognitiveDisorder
1-34	236-237	(	http://maven.renci.org/NeuroBridge/neurobridge#CognitiveDisorder
1-35	238-243	CocUD	http://maven.renci.org/NeuroBridge/neurobridge#CognitiveDisorder
1-36	244-245	)	http://maven.renci.org/NeuroBridge/neurobridge#CognitiveDisorder
1-37	246-247	.	_

Text=However, the neurobiology of attentional bias is not completely understood.
2-1	248-255	However	_
2-2	256-257	,	_
2-3	258-261	the	_
2-4	262-274	neurobiology	_
2-5	275-277	of	_
2-6	278-289	attentional	_
2-7	290-294	bias	_
2-8	295-297	is	_
2-9	298-301	not	_
2-10	302-312	completely	_
2-11	313-323	understood	_
2-12	324-325	.	_

Text=This study employed dynamic causal modeling (DCM) to conduct an analysis of effective (directional) connectivity involved in drug-related attentional bias in treatment-seeking CocUD subjects.
3-1	326-330	This	_
3-2	331-336	study	_
3-3	337-345	employed	_
3-4	346-353	dynamic	_
3-5	354-360	causal	_
3-6	361-369	modeling	_
3-7	370-371	(	_
3-8	372-375	DCM	_
3-9	376-377	)	_
3-10	378-380	to	_
3-11	381-388	conduct	_
3-12	389-391	an	_
3-13	392-400	analysis	_
3-14	401-403	of	_
3-15	404-413	effective	_
3-16	414-415	(	_
3-17	416-427	directional	_
3-18	428-429	)	_
3-19	430-442	connectivity	_
3-20	443-451	involved	_
3-21	452-454	in	_
3-22	455-467	drug-related	_
3-23	468-479	attentional	_
3-24	480-484	bias	_
3-25	485-487	in	_
3-26	488-505	treatment-seeking	_
3-27	506-511	CocUD	_
3-28	512-520	subjects	_
3-29	521-522	.	_

Text=The DCM analysis was conducted based on functional magnetic resonance imaging (fMRI) data acquired from fifteen CocUD subjects while performing a cocaine-word Stroop task, during which blocks of Cocaine Words (CW) and Neutral Words (NW) alternated.
4-1	523-526	The	_
4-2	527-530	DCM	_
4-3	531-539	analysis	_
4-4	540-543	was	_
4-5	544-553	conducted	_
4-6	554-559	based	_
4-7	560-562	on	_
4-8	563-573	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-9	574-582	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-10	583-592	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-11	593-600	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-12	601-602	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-13	603-607	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-14	608-609	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-15	610-614	data	_
4-16	615-623	acquired	_
4-17	624-628	from	_
4-18	629-636	fifteen	_
4-19	637-642	CocUD	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-20	643-651	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-21	652-657	while	_
4-22	658-668	performing	_
4-23	669-670	a	_
4-24	671-683	cocaine-word	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
4-25	684-690	Stroop	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
4-26	691-695	task	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
4-27	696-697	,	_
4-28	698-704	during	_
4-29	705-710	which	_
4-30	711-717	blocks	_
4-31	718-720	of	_
4-32	721-728	Cocaine	_
4-33	729-734	Words	_
4-34	735-736	(	_
4-35	737-739	CW	_
4-36	740-741	)	_
4-37	742-745	and	_
4-38	746-753	Neutral	_
4-39	754-759	Words	_
4-40	760-761	(	_
4-41	762-764	NW	_
4-42	765-766	)	_
4-43	767-777	alternated	_
4-44	778-779	.	_

Text=There was no significant attentional bias at group level.
5-1	780-785	There	_
5-2	786-789	was	_
5-3	790-792	no	_
5-4	793-804	significant	_
5-5	805-816	attentional	_
5-6	817-821	bias	_
5-7	822-824	at	_
5-8	825-830	group	_
5-9	831-836	level	_
5-10	837-838	.	_

Text=Although no significant brain activation was found, the DCM analysis found that, relative to the NW, the CW caused a significant increase in the strength of the right (R) anterior cingulate cortex (ACC) to R hippocampus effective connectivity.
6-1	839-847	Although	_
6-2	848-850	no	_
6-3	851-862	significant	_
6-4	863-868	brain	_
6-5	869-879	activation	_
6-6	880-883	was	_
6-7	884-889	found	_
6-8	890-891	,	_
6-9	892-895	the	_
6-10	896-899	DCM	_
6-11	900-908	analysis	_
6-12	909-914	found	_
6-13	915-919	that	_
6-14	920-921	,	_
6-15	922-930	relative	_
6-16	931-933	to	_
6-17	934-937	the	_
6-18	938-940	NW	_
6-19	941-942	,	_
6-20	943-946	the	_
6-21	947-949	CW	_
6-22	950-956	caused	_
6-23	957-958	a	_
6-24	959-970	significant	_
6-25	971-979	increase	_
6-26	980-982	in	_
6-27	983-986	the	_
6-28	987-995	strength	_
6-29	996-998	of	_
6-30	999-1002	the	_
6-31	1003-1008	right	_
6-32	1009-1010	(	_
6-33	1011-1012	R	_
6-34	1013-1014	)	_
6-35	1015-1023	anterior	_
6-36	1024-1033	cingulate	_
6-37	1034-1040	cortex	_
6-38	1041-1042	(	_
6-39	1043-1046	ACC	_
6-40	1047-1048	)	_
6-41	1049-1051	to	_
6-42	1052-1053	R	_
6-43	1054-1065	hippocampus	_
6-44	1066-1075	effective	_
6-45	1076-1088	connectivity	_
6-46	1089-1090	.	_

Text=Greater increase of this connectivity was associated with greater CW reaction time (relative to NW reaction time).
7-1	1091-1098	Greater	_
7-2	1099-1107	increase	_
7-3	1108-1110	of	_
7-4	1111-1115	this	_
7-5	1116-1128	connectivity	_
7-6	1129-1132	was	_
7-7	1133-1143	associated	_
7-8	1144-1148	with	_
7-9	1149-1156	greater	_
7-10	1157-1159	CW	_
7-11	1160-1168	reaction	_
7-12	1169-1173	time	_
7-13	1174-1175	(	_
7-14	1176-1184	relative	_
7-15	1185-1187	to	_
7-16	1188-1190	NW	_
7-17	1191-1199	reaction	_
7-18	1200-1204	time	_
7-19	1205-1206	)	_
7-20	1207-1208	.	_

Text=The increased strength of R ACC to R hippocampus connectivity may reflect ACC activation of hippocampal memories related to drug use, which was triggered by the drug cues.
8-1	1209-1212	The	_
8-2	1213-1222	increased	_
8-3	1223-1231	strength	_
8-4	1232-1234	of	_
8-5	1235-1236	R	_
8-6	1237-1240	ACC	_
8-7	1241-1243	to	_
8-8	1244-1245	R	_
8-9	1246-1257	hippocampus	_
8-10	1258-1270	connectivity	_
8-11	1271-1274	may	_
8-12	1275-1282	reflect	_
8-13	1283-1286	ACC	_
8-14	1287-1297	activation	_
8-15	1298-1300	of	_
8-16	1301-1312	hippocampal	_
8-17	1313-1321	memories	_
8-18	1322-1329	related	_
8-19	1330-1332	to	_
8-20	1333-1337	drug	_
8-21	1338-1341	use	_
8-22	1342-1343	,	_
8-23	1344-1349	which	_
8-24	1350-1353	was	_
8-25	1354-1363	triggered	_
8-26	1364-1366	by	_
8-27	1367-1370	the	_
8-28	1371-1375	drug	_
8-29	1376-1380	cues	_
8-30	1381-1382	.	_

Text=This circuit could be a potential target for therapeutics in CocUD patients.
9-1	1383-1387	This	_
9-2	1388-1395	circuit	_
9-3	1396-1401	could	_
9-4	1402-1404	be	_
9-5	1405-1406	a	_
9-6	1407-1416	potential	_
9-7	1417-1423	target	_
9-8	1424-1427	for	_
9-9	1428-1440	therapeutics	_
9-10	1441-1443	in	_
9-11	1444-1449	CocUD	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
9-12	1450-1458	patients	_
9-13	1459-1460	.	_

Text=No significant change was found in the other modeled connectivities.
10-1	1461-1463	No	_
10-2	1464-1475	significant	_
10-3	1476-1482	change	_
10-4	1483-1486	was	_
10-5	1487-1492	found	_
10-6	1493-1495	in	_
10-7	1496-1499	the	_
10-8	1500-1505	other	_
10-9	1506-1513	modeled	_
10-10	1514-1528	connectivities	_
10-11	1529-1530	.	_

Text=2.
11-1	1531-1532	2	_
11-2	1533-1534	.	_

Text=METHODS 2.1 Subjects The study was officially approved by the local Institutional Review Board, and was performed in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki).
12-1	1535-1542	METHODS	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
12-2	1543-1546	2.1	_
12-3	1547-1555	Subjects	_
12-4	1556-1559	The	_
12-5	1560-1565	study	_
12-6	1566-1569	was	_
12-7	1570-1580	officially	_
12-8	1581-1589	approved	_
12-9	1590-1592	by	_
12-10	1593-1596	the	_
12-11	1597-1602	local	_
12-12	1603-1616	Institutional	_
12-13	1617-1623	Review	_
12-14	1624-1629	Board	_
12-15	1630-1631	,	_
12-16	1632-1635	and	_
12-17	1636-1639	was	_
12-18	1640-1649	performed	_
12-19	1650-1652	in	_
12-20	1653-1663	accordance	_
12-21	1664-1668	with	_
12-22	1669-1672	the	_
12-23	1673-1677	Code	_
12-24	1678-1680	of	_
12-25	1681-1687	Ethics	_
12-26	1688-1690	of	_
12-27	1691-1694	the	_
12-28	1695-1700	World	_
12-29	1701-1708	Medical	_
12-30	1709-1720	Association	_
12-31	1721-1722	(	_
12-32	1723-1734	Declaration	_
12-33	1735-1737	of	_
12-34	1738-1746	Helsinki	_
12-35	1747-1748	)	_
12-36	1749-1750	.	_

Text=Informed consent was obtained from each subject.
13-1	1751-1759	Informed	_
13-2	1760-1767	consent	_
13-3	1768-1771	was	_
13-4	1772-1780	obtained	_
13-5	1781-1785	from	_
13-6	1786-1790	each	_
13-7	1791-1798	subject	_
13-8	1799-1800	.	_

Text=The CocUD subjects were from a treatment study, in which the majority of the participants were male.
14-1	1801-1804	The	_
14-2	1805-1810	CocUD	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
14-3	1811-1819	subjects	_
14-4	1820-1824	were	_
14-5	1825-1829	from	_
14-6	1830-1831	a	_
14-7	1832-1841	treatment	_
14-8	1842-1847	study	_
14-9	1848-1849	,	_
14-10	1850-1852	in	_
14-11	1853-1858	which	_
14-12	1859-1862	the	_
14-13	1863-1871	majority	_
14-14	1872-1874	of	_
14-15	1875-1878	the	_
14-16	1879-1891	participants	_
14-17	1892-1896	were	_
14-18	1897-1901	male	_
14-19	1902-1903	.	_

Text=All MRI scans took place prior to the initiation of medication treatment.
15-1	1904-1907	All	_
15-2	1908-1911	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
15-3	1912-1917	scans	_
15-4	1918-1922	took	_
15-5	1923-1928	place	_
15-6	1929-1934	prior	_
15-7	1935-1937	to	_
15-8	1938-1941	the	_
15-9	1942-1952	initiation	_
15-10	1953-1955	of	_
15-11	1956-1966	medication	_
15-12	1967-1976	treatment	_
15-13	1977-1978	.	_

Text=All subjects were screened using the Structured Clinical Interview for DSM-IV (SCID) and underwent physical examination and medical history.
16-1	1979-1982	All	_
16-2	1983-1991	subjects	_
16-3	1992-1996	were	_
16-4	1997-2005	screened	_
16-5	2006-2011	using	_
16-6	2012-2015	the	_
16-7	2016-2026	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-8	2027-2035	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-9	2036-2045	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-10	2046-2049	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-11	2050-2056	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-12	2057-2058	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-13	2059-2063	SCID	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-14	2064-2065	)	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-15	2066-2069	and	_
16-16	2070-2079	underwent	_
16-17	2080-2088	physical	_
16-18	2089-2100	examination	_
16-19	2101-2104	and	_
16-20	2105-2112	medical	_
16-21	2113-2120	history	_
16-22	2121-2122	.	_

Text=The Addiction Severity Index was obtained to document lifetime drug and alcohol use.
17-1	2123-2126	The	_
17-2	2127-2136	Addiction	_
17-3	2137-2145	Severity	_
17-4	2146-2151	Index	_
17-5	2152-2155	was	_
17-6	2156-2164	obtained	_
17-7	2165-2167	to	_
17-8	2168-2176	document	_
17-9	2177-2185	lifetime	_
17-10	2186-2190	drug	_
17-11	2191-2194	and	_
17-12	2195-2202	alcohol	_
17-13	2203-2206	use	_
17-14	2207-2208	.	_

Text=Female subjects were screened with a urine pregnancy test immediately prior to MRI scanning.
18-1	2209-2215	Female	_
18-2	2216-2224	subjects	_
18-3	2225-2229	were	_
18-4	2230-2238	screened	_
18-5	2239-2243	with	_
18-6	2244-2245	a	_
18-7	2246-2251	urine	_
18-8	2252-2261	pregnancy	_
18-9	2262-2266	test	_
18-10	2267-2278	immediately	_
18-11	2279-2284	prior	_
18-12	2285-2287	to	_
18-13	2288-2291	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
18-14	2292-2300	scanning	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
18-15	2301-2302	.	_

Text=Each subject ’ s urine was screened for tetrahydrocannabinol (THC), opiates, cocaine, amphetamines, and benzodiazepines (Syva Company, Deerfield, IL), and each subject was screened for alcohol with an Intoximeter Alco-Sensor III breathalyzer (Intoximeters, Inc., St. Louis, MO) immediately prior to MRI scanning.
19-1	2303-2307	Each	_
19-2	2308-2315	subject	_
19-3	2316-2317	’	_
19-4	2318-2319	s	_
19-5	2320-2325	urine	_
19-6	2326-2329	was	_
19-7	2330-2338	screened	_
19-8	2339-2342	for	_
19-9	2343-2363	tetrahydrocannabinol	_
19-10	2364-2365	(	_
19-11	2366-2369	THC	_
19-12	2370-2371	)	_
19-13	2372-2373	,	_
19-14	2374-2381	opiates	_
19-15	2382-2383	,	_
19-16	2384-2391	cocaine	_
19-17	2392-2393	,	_
19-18	2394-2406	amphetamines	_
19-19	2407-2408	,	_
19-20	2409-2412	and	_
19-21	2413-2428	benzodiazepines	_
19-22	2429-2430	(	_
19-23	2431-2435	Syva	_
19-24	2436-2443	Company	_
19-25	2444-2445	,	_
19-26	2446-2455	Deerfield	_
19-27	2456-2457	,	_
19-28	2458-2460	IL	_
19-29	2461-2462	)	_
19-30	2463-2464	,	_
19-31	2465-2468	and	_
19-32	2469-2473	each	_
19-33	2474-2481	subject	_
19-34	2482-2485	was	_
19-35	2486-2494	screened	_
19-36	2495-2498	for	_
19-37	2499-2506	alcohol	_
19-38	2507-2511	with	_
19-39	2512-2514	an	_
19-40	2515-2526	Intoximeter	_
19-41	2527-2538	Alco-Sensor	_
19-42	2539-2542	III	_
19-43	2543-2555	breathalyzer	_
19-44	2556-2557	(	_
19-45	2558-2570	Intoximeters	_
19-46	2571-2572	,	_
19-47	2573-2577	Inc.	_
19-48	2578-2579	,	_
19-49	2580-2583	St.	_
19-50	2584-2589	Louis	_
19-51	2590-2591	,	_
19-52	2592-2594	MO	_
19-53	2595-2596	)	_
19-54	2597-2608	immediately	_
19-55	2609-2614	prior	_
19-56	2615-2617	to	_
19-57	2618-2621	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
19-58	2622-2630	scanning	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
19-59	2631-2632	.	_

Text=Subject inclusion criteria were: (1) 18–55 years old; (2) right-handed; (3) free of alcohol at the time of MRI scanning; (4) met Diagnostic and Statistical Manual Fourth Edition (DSM-IV) criteria for current cocaine dependence based on the Structured Clinical Interview for DSM-IV.
20-1	2633-2640	Subject	_
20-2	2641-2650	inclusion	_
20-3	2651-2659	criteria	_
20-4	2660-2664	were	_
20-5	2665-2666	:	_
20-6	2667-2668	(	_
20-7	2669-2670	1	_
20-8	2671-2672	)	_
20-9	2673-2678	18–55	_
20-10	2679-2684	years	_
20-11	2685-2688	old	_
20-12	2689-2690	;	_
20-13	2691-2692	(	_
20-14	2693-2694	2	_
20-15	2695-2696	)	_
20-16	2697-2709	right-handed	_
20-17	2710-2711	;	_
20-18	2712-2713	(	_
20-19	2714-2715	3	_
20-20	2716-2717	)	_
20-21	2718-2722	free	_
20-22	2723-2725	of	_
20-23	2726-2733	alcohol	_
20-24	2734-2736	at	_
20-25	2737-2740	the	_
20-26	2741-2745	time	_
20-27	2746-2748	of	_
20-28	2749-2752	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
20-29	2753-2761	scanning	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
20-30	2762-2763	;	_
20-31	2764-2765	(	_
20-32	2766-2767	4	_
20-33	2768-2769	)	_
20-34	2770-2773	met	_
20-35	2774-2784	Diagnostic	_
20-36	2785-2788	and	_
20-37	2789-2800	Statistical	_
20-38	2801-2807	Manual	_
20-39	2808-2814	Fourth	_
20-40	2815-2822	Edition	_
20-41	2823-2824	(	_
20-42	2825-2831	DSM-IV	_
20-43	2832-2833	)	_
20-44	2834-2842	criteria	_
20-45	2843-2846	for	_
20-46	2847-2854	current	_
20-47	2855-2862	cocaine	_
20-48	2863-2873	dependence	_
20-49	2874-2879	based	_
20-50	2880-2882	on	_
20-51	2883-2886	the	_
20-52	2887-2897	Structured	_
20-53	2898-2906	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
20-54	2907-2916	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
20-55	2917-2920	for	_
20-56	2921-2927	DSM-IV	_
20-57	2928-2929	.	_

Text=Exclusion criteria were: (1) subjects who met current or past DSM-IV Axis I disorder other than substance abuse or substance dependence; (2) medical disorders or taking medication that may affect the central nervous system; (3) claustrophobia experienced during MRI or MRI simulator sessions; (4) any definite or suspected clinically significant abnormalities of the brain on Fluid Attenuated Inversion Recovery (FLAIR) MRI scans; (5) positive pregnancy test result.
21-1	2930-2939	Exclusion	_
21-2	2940-2948	criteria	_
21-3	2949-2953	were	_
21-4	2954-2955	:	_
21-5	2956-2957	(	_
21-6	2958-2959	1	_
21-7	2960-2961	)	_
21-8	2962-2970	subjects	_
21-9	2971-2974	who	_
21-10	2975-2978	met	_
21-11	2979-2986	current	_
21-12	2987-2989	or	_
21-13	2990-2994	past	_
21-14	2995-3001	DSM-IV	_
21-15	3002-3006	Axis	_
21-16	3007-3008	I	_
21-17	3009-3017	disorder	_
21-18	3018-3023	other	_
21-19	3024-3028	than	_
21-20	3029-3038	substance	_
21-21	3039-3044	abuse	_
21-22	3045-3047	or	_
21-23	3048-3057	substance	_
21-24	3058-3068	dependence	_
21-25	3069-3070	;	_
21-26	3071-3072	(	_
21-27	3073-3074	2	_
21-28	3075-3076	)	_
21-29	3077-3084	medical	_
21-30	3085-3094	disorders	_
21-31	3095-3097	or	_
21-32	3098-3104	taking	_
21-33	3105-3115	medication	_
21-34	3116-3120	that	_
21-35	3121-3124	may	_
21-36	3125-3131	affect	_
21-37	3132-3135	the	_
21-38	3136-3143	central	_
21-39	3144-3151	nervous	_
21-40	3152-3158	system	_
21-41	3159-3160	;	_
21-42	3161-3162	(	_
21-43	3163-3164	3	_
21-44	3165-3166	)	_
21-45	3167-3181	claustrophobia	_
21-46	3182-3193	experienced	_
21-47	3194-3200	during	_
21-48	3201-3204	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
21-49	3205-3207	or	_
21-50	3208-3211	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
21-51	3212-3221	simulator	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
21-52	3222-3230	sessions	_
21-53	3231-3232	;	_
21-54	3233-3234	(	_
21-55	3235-3236	4	_
21-56	3237-3238	)	_
21-57	3239-3242	any	_
21-58	3243-3251	definite	_
21-59	3252-3254	or	_
21-60	3255-3264	suspected	_
21-61	3265-3275	clinically	_
21-62	3276-3287	significant	_
21-63	3288-3301	abnormalities	_
21-64	3302-3304	of	_
21-65	3305-3308	the	_
21-66	3309-3314	brain	_
21-67	3315-3317	on	_
21-68	3318-3323	Fluid	http://maven.renci.org/NeuroBridge/neurobridge#FluidAttenuatedInversionRecoveryImaging
21-69	3324-3334	Attenuated	_
21-70	3335-3344	Inversion	http://maven.renci.org/NeuroBridge/neurobridge#FluidAttenuatedInversionRecoveryImaging
21-71	3345-3353	Recovery	http://maven.renci.org/NeuroBridge/neurobridge#FluidAttenuatedInversionRecoveryImaging
21-72	3354-3355	(	_
21-73	3356-3361	FLAIR	_
21-74	3362-3363	)	http://maven.renci.org/NeuroBridge/neurobridge#Thing
21-75	3364-3367	MRI	_
21-76	3368-3373	scans	_
21-77	3374-3375	;	_
21-78	3376-3377	(	_
21-79	3378-3379	5	_
21-80	3380-3381	)	_
21-81	3382-3390	positive	_
21-82	3391-3400	pregnancy	_
21-83	3401-3405	test	_
21-84	3406-3412	result	_
21-85	3413-3414	.	_

Text=Based on above criteria, fifteen CocUD subjects, among the 26 CocUD subjects who were scanned, were included for final analysis.
22-1	3415-3420	Based	_
22-2	3421-3423	on	_
22-3	3424-3429	above	_
22-4	3430-3438	criteria	_
22-5	3439-3440	,	_
22-6	3441-3448	fifteen	_
22-7	3449-3454	CocUD	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
22-8	3455-3463	subjects	_
22-9	3464-3465	,	_
22-10	3466-3471	among	_
22-11	3472-3475	the	_
22-12	3476-3478	26	_
22-13	3479-3484	CocUD	_
22-14	3485-3493	subjects	_
22-15	3494-3497	who	_
22-16	3498-3502	were	_
22-17	3503-3510	scanned	_
22-18	3511-3512	,	_
22-19	3513-3517	were	_
22-20	3518-3526	included	_
22-21	3527-3530	for	_
22-22	3531-3536	final	_
22-23	3537-3545	analysis	_
22-24	3546-3547	.	_

Text=See Table 1 for the demographics and drug-use information of these subjects.
23-1	3548-3551	See	_
23-2	3552-3557	Table	_
23-3	3558-3559	1	_
23-4	3560-3563	for	_
23-5	3564-3567	the	_
23-6	3568-3580	demographics	_
23-7	3581-3584	and	_
23-8	3585-3593	drug-use	_
23-9	3594-3605	information	_
23-10	3606-3608	of	_
23-11	3609-3614	these	_
23-12	3615-3623	subjects	_
23-13	3624-3625	.	_

Text=This is a free-standing study; all the CocUD subjects (n=26) who were scanned were considered.
24-1	3626-3630	This	_
24-2	3631-3633	is	_
24-3	3634-3635	a	_
24-4	3636-3649	free-standing	_
24-5	3650-3655	study	_
24-6	3656-3657	;	_
24-7	3658-3661	all	_
24-8	3662-3665	the	_
24-9	3666-3671	CocUD	_
24-10	3672-3680	subjects	_
24-11	3681-3682	(	_
24-12	3683-3687	n=26	_
24-13	3688-3689	)	_
24-14	3690-3693	who	_
24-15	3694-3698	were	_
24-16	3699-3706	scanned	_
24-17	3707-3711	were	_
24-18	3712-3722	considered	_
24-19	3723-3724	.	_

Text=Eleven CocUD subjects were excuded because of either missing behavioral performance data (n=1); excessive head motion during the fMRI scan (n=2); clinically significant abnormal results on FLAIR scan of the brain (n=4); subject ’ s request to terminate the scanning (n=2); or current alcohol dependence (n=2).
25-1	3725-3731	Eleven	_
25-2	3732-3737	CocUD	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
25-3	3738-3746	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
25-4	3747-3751	were	_
25-5	3752-3759	excuded	_
25-6	3760-3767	because	_
25-7	3768-3770	of	_
25-8	3771-3777	either	_
25-9	3778-3785	missing	_
25-10	3786-3796	behavioral	_
25-11	3797-3808	performance	_
25-12	3809-3813	data	_
25-13	3814-3815	(	_
25-14	3816-3819	n=1	_
25-15	3820-3821	)	_
25-16	3822-3823	;	_
25-17	3824-3833	excessive	_
25-18	3834-3838	head	_
25-19	3839-3845	motion	_
25-20	3846-3852	during	_
25-21	3853-3856	the	_
25-22	3857-3861	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
25-23	3862-3866	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
25-24	3867-3868	(	_
25-25	3869-3872	n=2	_
25-26	3873-3874	)	_
25-27	3875-3876	;	_
25-28	3877-3887	clinically	_
25-29	3888-3899	significant	_
25-30	3900-3908	abnormal	_
25-31	3909-3916	results	_
25-32	3917-3919	on	_
25-33	3920-3925	FLAIR	_
25-34	3926-3930	scan	_
25-35	3931-3933	of	_
25-36	3934-3937	the	_
25-37	3938-3943	brain	_
25-38	3944-3945	(	_
25-39	3946-3949	n=4	_
25-40	3950-3951	)	_
25-41	3952-3953	;	_
25-42	3954-3961	subject	_
25-43	3962-3963	’	_
25-44	3964-3965	s	_
25-45	3966-3973	request	_
25-46	3974-3976	to	_
25-47	3977-3986	terminate	_
25-48	3987-3990	the	_
25-49	3991-3999	scanning	_
25-50	4000-4001	(	_
25-51	4002-4005	n=2	_
25-52	4006-4007	)	_
25-53	4008-4009	;	_
25-54	4010-4012	or	_
25-55	4013-4020	current	_
25-56	4021-4028	alcohol	_
25-57	4029-4039	dependence	_
25-58	4040-4041	(	_
25-59	4042-4045	n=2	_
25-60	4046-4047	)	_
25-61	4048-4049	.	_

Text=The majority of the participants were male.
26-1	4050-4053	The	_
26-2	4054-4062	majority	_
26-3	4063-4065	of	_
26-4	4066-4069	the	_
26-5	4070-4082	participants	_
26-6	4083-4087	were	_
26-7	4088-4092	male	_
26-8	4093-4094	.	_

Text=The one female subject who was scanned was excluded because of excessive head motion.
27-1	4095-4098	The	_
27-2	4099-4102	one	_
27-3	4103-4109	female	_
27-4	4110-4117	subject	_
27-5	4118-4121	who	_
27-6	4122-4125	was	_
27-7	4126-4133	scanned	_
27-8	4134-4137	was	_
27-9	4138-4146	excluded	_
27-10	4147-4154	because	_
27-11	4155-4157	of	_
27-12	4158-4167	excessive	_
27-13	4168-4172	head	_
27-14	4173-4179	motion	_
27-15	4180-4181	.	_

Text=2.2 Cocaine-word Stroop fMRI Task The subject was presented with ten cocaine words (CW) and ten neutral words (NW), one word at a time.
28-1	4182-4185	2.2	_
28-2	4186-4198	Cocaine-word	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
28-3	4199-4205	Stroop	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
28-4	4206-4210	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
28-5	4211-4215	Task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
28-6	4216-4219	The	_
28-7	4220-4227	subject	_
28-8	4228-4231	was	_
28-9	4232-4241	presented	_
28-10	4242-4246	with	_
28-11	4247-4250	ten	_
28-12	4251-4258	cocaine	_
28-13	4259-4264	words	_
28-14	4265-4266	(	_
28-15	4267-4269	CW	_
28-16	4270-4271	)	_
28-17	4272-4275	and	_
28-18	4276-4279	ten	_
28-19	4280-4287	neutral	_
28-20	4288-4293	words	_
28-21	4294-4295	(	_
28-22	4296-4298	NW	_
28-23	4299-4300	)	_
28-24	4301-4302	,	_
28-25	4303-4306	one	_
28-26	4307-4311	word	_
28-27	4312-4314	at	_
28-28	4315-4316	a	_
28-29	4317-4321	time	_
28-30	4322-4323	.	_

Text=The CW and NW were matched in letter length.
29-1	4324-4327	The	_
29-2	4328-4330	CW	_
29-3	4331-4334	and	_
29-4	4335-4337	NW	_
29-5	4338-4342	were	_
29-6	4343-4350	matched	_
29-7	4351-4353	in	_
29-8	4354-4360	letter	_
29-9	4361-4367	length	_
29-10	4368-4369	.	_

Text=Both CW (e.g., “ cocaine ”, “ crack ”) and NW (e.g., “ kitchen ”, “ table ”) were frequently used words in the English language.
30-1	4370-4374	Both	_
30-2	4375-4377	CW	_
30-3	4378-4379	(	_
30-4	4380-4384	e.g.	_
30-5	4385-4386	,	_
30-6	4387-4388	“	_
30-7	4389-4396	cocaine	_
30-8	4397-4398	”	_
30-9	4399-4400	,	_
30-10	4401-4402	“	_
30-11	4403-4408	crack	_
30-12	4409-4410	”	_
30-13	4411-4412	)	_
30-14	4413-4416	and	_
30-15	4417-4419	NW	_
30-16	4420-4421	(	_
30-17	4422-4426	e.g.	_
30-18	4427-4428	,	_
30-19	4429-4430	“	_
30-20	4431-4438	kitchen	_
30-21	4439-4440	”	_
30-22	4441-4442	,	_
30-23	4443-4444	“	_
30-24	4445-4450	table	_
30-25	4451-4452	”	_
30-26	4453-4454	)	_
30-27	4455-4459	were	_
30-28	4460-4470	frequently	_
30-29	4471-4475	used	_
30-30	4476-4481	words	_
30-31	4482-4484	in	_
30-32	4485-4488	the	_
30-33	4489-4496	English	_
30-34	4497-4505	language	_
30-35	4506-4507	.	_

Text=Each word when presented was randomly printed in one of three different colors (blue, green, or red).
31-1	4508-4512	Each	_
31-2	4513-4517	word	_
31-3	4518-4522	when	_
31-4	4523-4532	presented	_
31-5	4533-4536	was	_
31-6	4537-4545	randomly	_
31-7	4546-4553	printed	_
31-8	4554-4556	in	_
31-9	4557-4560	one	_
31-10	4561-4563	of	_
31-11	4564-4569	three	_
31-12	4570-4579	different	_
31-13	4580-4586	colors	_
31-14	4587-4588	(	_
31-15	4589-4593	blue	_
31-16	4594-4595	,	_
31-17	4596-4601	green	_
31-18	4602-4603	,	_
31-19	4604-4606	or	_
31-20	4607-4610	red	_
31-21	4611-4612	)	_
31-22	4613-4614	.	_

Text=The subject was instructed to ignore the meaning of the word and to press the appropriate button to denote the color in which the word was printed.
32-1	4615-4618	The	_
32-2	4619-4626	subject	_
32-3	4627-4630	was	_
32-4	4631-4641	instructed	_
32-5	4642-4644	to	_
32-6	4645-4651	ignore	_
32-7	4652-4655	the	_
32-8	4656-4663	meaning	_
32-9	4664-4666	of	_
32-10	4667-4670	the	_
32-11	4671-4675	word	_
32-12	4676-4679	and	_
32-13	4680-4682	to	_
32-14	4683-4688	press	_
32-15	4689-4692	the	_
32-16	4693-4704	appropriate	_
32-17	4705-4711	button	_
32-18	4712-4714	to	_
32-19	4715-4721	denote	_
32-20	4722-4725	the	_
32-21	4726-4731	color	_
32-22	4732-4734	in	_
32-23	4735-4740	which	_
32-24	4741-4744	the	_
32-25	4745-4749	word	_
32-26	4750-4753	was	_
32-27	4754-4761	printed	_
32-28	4762-4763	.	_

Text=Each word was shown for a maximum duration of 1800 ms (if no response), but the display of the word was terminated by a response, after which a blank screen was shown for the remainder of the trial up to 1900 ms.
33-1	4764-4768	Each	_
33-2	4769-4773	word	_
33-3	4774-4777	was	_
33-4	4778-4783	shown	_
33-5	4784-4787	for	_
33-6	4788-4789	a	_
33-7	4790-4797	maximum	_
33-8	4798-4806	duration	_
33-9	4807-4809	of	_
33-10	4810-4814	1800	_
33-11	4815-4817	ms	_
33-12	4818-4819	(	_
33-13	4820-4822	if	_
33-14	4823-4825	no	_
33-15	4826-4834	response	_
33-16	4835-4836	)	_
33-17	4837-4838	,	_
33-18	4839-4842	but	_
33-19	4843-4846	the	_
33-20	4847-4854	display	_
33-21	4855-4857	of	_
33-22	4858-4861	the	_
33-23	4862-4866	word	_
33-24	4867-4870	was	_
33-25	4871-4881	terminated	_
33-26	4882-4884	by	_
33-27	4885-4886	a	_
33-28	4887-4895	response	_
33-29	4896-4897	,	_
33-30	4898-4903	after	_
33-31	4904-4909	which	_
33-32	4910-4911	a	_
33-33	4912-4917	blank	_
33-34	4918-4924	screen	_
33-35	4925-4928	was	_
33-36	4929-4934	shown	_
33-37	4935-4938	for	_
33-38	4939-4942	the	_
33-39	4943-4952	remainder	_
33-40	4953-4955	of	_
33-41	4956-4959	the	_
33-42	4960-4965	trial	_
33-43	4966-4968	up	_
33-44	4969-4971	to	_
33-45	4972-4976	1900	_
33-46	4977-4979	ms	_
33-47	4980-4981	.	_

Text=The next trial immediately began with the presentation of the next word.
34-1	4982-4985	The	_
34-2	4986-4990	next	_
34-3	4991-4996	trial	_
34-4	4997-5008	immediately	_
34-5	5009-5014	began	_
34-6	5015-5019	with	_
34-7	5020-5023	the	_
34-8	5024-5036	presentation	_
34-9	5037-5039	of	_
34-10	5040-5043	the	_
34-11	5044-5048	next	_
34-12	5049-5053	word	_
34-13	5054-5055	.	_

Text=Four CW blocks and four NW blocks alternated with a 12 s pause between blocks.
35-1	5056-5060	Four	_
35-2	5061-5063	CW	_
35-3	5064-5070	blocks	_
35-4	5071-5074	and	_
35-5	5075-5079	four	_
35-6	5080-5082	NW	_
35-7	5083-5089	blocks	_
35-8	5090-5100	alternated	_
35-9	5101-5105	with	_
35-10	5106-5107	a	_
35-11	5108-5110	12	_
35-12	5111-5112	s	_
35-13	5113-5118	pause	_
35-14	5119-5126	between	_
35-15	5127-5133	blocks	_
35-16	5134-5135	.	_

Text=Within each block (58 s per block), thirty words were presented.
36-1	5136-5142	Within	_
36-2	5143-5147	each	_
36-3	5148-5153	block	_
36-4	5154-5155	(	_
36-5	5156-5158	58	_
36-6	5159-5160	s	_
36-7	5161-5164	per	_
36-8	5165-5170	block	_
36-9	5171-5172	)	_
36-10	5173-5174	,	_
36-11	5175-5181	thirty	_
36-12	5182-5187	words	_
36-13	5188-5192	were	_
36-14	5193-5202	presented	_
36-15	5203-5204	.	_

Text=The effect of drug cues on the reaction times (ΔRT) was measured by the mean reaction time during all the CW blocks minus that during all of the NW blocks, i.e., ΔRT = RT (CW) minus RT (NW).
37-1	5205-5208	The	_
37-2	5209-5215	effect	_
37-3	5216-5218	of	_
37-4	5219-5223	drug	_
37-5	5224-5228	cues	_
37-6	5229-5231	on	_
37-7	5232-5235	the	_
37-8	5236-5244	reaction	_
37-9	5245-5250	times	_
37-10	5251-5252	(	_
37-11	5253-5256	ΔRT	_
37-12	5257-5258	)	_
37-13	5259-5262	was	_
37-14	5263-5271	measured	_
37-15	5272-5274	by	_
37-16	5275-5278	the	_
37-17	5279-5283	mean	_
37-18	5284-5292	reaction	_
37-19	5293-5297	time	_
37-20	5298-5304	during	_
37-21	5305-5308	all	_
37-22	5309-5312	the	_
37-23	5313-5315	CW	_
37-24	5316-5322	blocks	_
37-25	5323-5328	minus	_
37-26	5329-5333	that	_
37-27	5334-5340	during	_
37-28	5341-5344	all	_
37-29	5345-5347	of	_
37-30	5348-5351	the	_
37-31	5352-5354	NW	_
37-32	5355-5361	blocks	_
37-33	5362-5363	,	_
37-34	5364-5368	i.e.	_
37-35	5369-5370	,	_
37-36	5371-5374	ΔRT	_
37-37	5375-5376	=	_
37-38	5377-5379	RT	_
37-39	5380-5381	(	_
37-40	5382-5384	CW	_
37-41	5385-5386	)	_
37-42	5387-5392	minus	_
37-43	5393-5395	RT	_
37-44	5396-5397	(	_
37-45	5398-5400	NW	_
37-46	5401-5402	)	_
37-47	5403-5404	.	_

Text=Only the correct-response trials were included when calculating the mean reaction times.
38-1	5405-5409	Only	_
38-2	5410-5413	the	_
38-3	5414-5430	correct-response	_
38-4	5431-5437	trials	_
38-5	5438-5442	were	_
38-6	5443-5451	included	_
38-7	5452-5456	when	_
38-8	5457-5468	calculating	_
38-9	5469-5472	the	_
38-10	5473-5477	mean	_
38-11	5478-5486	reaction	_
38-12	5487-5492	times	_
38-13	5493-5494	.	_

Text=ΔRT was treated as a measure of attentional bias at the behavioral level in the present study.
39-1	5495-5498	ΔRT	_
39-2	5499-5502	was	_
39-3	5503-5510	treated	_
39-4	5511-5513	as	_
39-5	5514-5515	a	_
39-6	5516-5523	measure	_
39-7	5524-5526	of	_
39-8	5527-5538	attentional	_
39-9	5539-5543	bias	_
39-10	5544-5546	at	_
39-11	5547-5550	the	_
39-12	5551-5561	behavioral	_
39-13	5562-5567	level	_
39-14	5568-5570	in	_
39-15	5571-5574	the	_
39-16	5575-5582	present	_
39-17	5583-5588	study	_
39-18	5589-5590	.	_

Text=2.3 fMRI Data Acquisition MRI data were acquired on a Philips 3.0 T Intera system with an eight channel receive head coil (Philips Medical Systems, Best, Netherlands).
40-1	5591-5594	2.3	_
40-2	5595-5599	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-3	5600-5604	Data	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
40-4	5605-5616	Acquisition	_
40-5	5617-5620	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
40-6	5621-5625	data	_
40-7	5626-5630	were	_
40-8	5631-5639	acquired	_
40-9	5640-5642	on	_
40-10	5643-5644	a	_
40-11	5645-5652	Philips	_
40-12	5653-5656	3.0	http://maven.renci.org/NeuroBridge/neurobridge#ReproductiveDisease
40-13	5657-5658	T	http://maven.renci.org/NeuroBridge/neurobridge#ReproductiveDisease
40-14	5659-5665	Intera	http://maven.renci.org/NeuroBridge/neurobridge#ReproductiveDisease
40-15	5666-5672	system	http://maven.renci.org/NeuroBridge/neurobridge#ReproductiveDisease
40-16	5673-5677	with	_
40-17	5678-5680	an	_
40-18	5681-5686	eight	_
40-19	5687-5694	channel	_
40-20	5695-5702	receive	_
40-21	5703-5707	head	_
40-22	5708-5712	coil	_
40-23	5713-5714	(	_
40-24	5715-5722	Philips	_
40-25	5723-5730	Medical	_
40-26	5731-5738	Systems	_
40-27	5739-5740	,	_
40-28	5741-5745	Best	_
40-29	5746-5747	,	_
40-30	5748-5759	Netherlands	_
40-31	5760-5761	)	_
40-32	5762-5763	.	_

Text=Single shot spin echo echoplanar imaging (EPI) was used for acquiring fMRI data.
41-1	5764-5770	Single	_
41-2	5771-5775	shot	_
41-3	5776-5780	spin	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
41-4	5781-5785	echo	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
41-5	5786-5796	echoplanar	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
41-6	5797-5804	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
41-7	5805-5806	(	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
41-8	5807-5810	EPI	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
41-9	5811-5812	)	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
41-10	5813-5816	was	_
41-11	5817-5821	used	_
41-12	5822-5825	for	_
41-13	5826-5835	acquiring	_
41-14	5836-5840	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
41-15	5841-5845	data	_
41-16	5846-5847	.	_

Text=The fMRI acquisition parameters were: SENSE acceleration factor 2.0, repetition time 2500 ms, echo time 75 ms, flip angle 90 degrees, field of view 240 mm × 240 mm, in-plane resolution 3.75 mm × 3.75 mm, 25 axial slices, slice thickness 3.75 mm, interslice gap 1.25 mm, 224 repetitions per run after 10 dummy acquisitions, total duration per run was 10 min 40 s. 2.4 fMRI Preprocessing During an fMRI run, individual scans in which the fMRI signal exceeded plus or minus four standard deviations from the mean were considered to be outliers and were replaced by the mean of the two nearest neighbors using the Analysis of Functional NeuroImages (AFNI) software command “ 3dDespike ” (http: //afni.nimh.nih.gov/afni/).
42-1	5848-5851	The	_
42-2	5852-5856	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
42-3	5857-5868	acquisition	_
42-4	5869-5879	parameters	_
42-5	5880-5884	were	_
42-6	5885-5886	:	_
42-7	5887-5892	SENSE	_
42-8	5893-5905	acceleration	_
42-9	5906-5912	factor	_
42-10	5913-5916	2.0	_
42-11	5917-5918	,	_
42-12	5919-5929	repetition	_
42-13	5930-5934	time	_
42-14	5935-5939	2500	_
42-15	5940-5942	ms	_
42-16	5943-5944	,	_
42-17	5945-5949	echo	_
42-18	5950-5954	time	_
42-19	5955-5957	75	_
42-20	5958-5960	ms	_
42-21	5961-5962	,	_
42-22	5963-5967	flip	_
42-23	5968-5973	angle	_
42-24	5974-5976	90	_
42-25	5977-5984	degrees	_
42-26	5985-5986	,	_
42-27	5987-5992	field	_
42-28	5993-5995	of	_
42-29	5996-6000	view	_
42-30	6001-6004	240	_
42-31	6005-6007	mm	_
42-32	6008-6009	×	_
42-33	6010-6013	240	_
42-34	6014-6016	mm	_
42-35	6017-6018	,	_
42-36	6019-6027	in-plane	_
42-37	6028-6038	resolution	_
42-38	6039-6043	3.75	_
42-39	6044-6046	mm	_
42-40	6047-6048	×	_
42-41	6049-6053	3.75	_
42-42	6054-6056	mm	_
42-43	6057-6058	,	_
42-44	6059-6061	25	_
42-45	6062-6067	axial	_
42-46	6068-6074	slices	_
42-47	6075-6076	,	_
42-48	6077-6082	slice	_
42-49	6083-6092	thickness	_
42-50	6093-6097	3.75	_
42-51	6098-6100	mm	_
42-52	6101-6102	,	_
42-53	6103-6113	interslice	_
42-54	6114-6117	gap	_
42-55	6118-6122	1.25	_
42-56	6123-6125	mm	_
42-57	6126-6127	,	_
42-58	6128-6131	224	_
42-59	6132-6143	repetitions	_
42-60	6144-6147	per	_
42-61	6148-6151	run	_
42-62	6152-6157	after	_
42-63	6158-6160	10	_
42-64	6161-6166	dummy	_
42-65	6167-6179	acquisitions	_
42-66	6180-6181	,	_
42-67	6182-6187	total	_
42-68	6188-6196	duration	_
42-69	6197-6200	per	_
42-70	6201-6204	run	_
42-71	6205-6208	was	_
42-72	6209-6211	10	_
42-73	6212-6215	min	_
42-74	6216-6218	40	_
42-75	6219-6221	s.	_
42-76	6222-6225	2.4	_
42-77	6226-6230	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
42-78	6231-6244	Preprocessing	_
42-79	6245-6251	During	_
42-80	6252-6254	an	_
42-81	6255-6259	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
42-82	6260-6263	run	_
42-83	6264-6265	,	_
42-84	6266-6276	individual	_
42-85	6277-6282	scans	_
42-86	6283-6285	in	_
42-87	6286-6291	which	_
42-88	6292-6295	the	_
42-89	6296-6300	fMRI	_
42-90	6301-6307	signal	_
42-91	6308-6316	exceeded	_
42-92	6317-6321	plus	_
42-93	6322-6324	or	_
42-94	6325-6330	minus	_
42-95	6331-6335	four	_
42-96	6336-6344	standard	_
42-97	6345-6355	deviations	_
42-98	6356-6360	from	_
42-99	6361-6364	the	_
42-100	6365-6369	mean	_
42-101	6370-6374	were	_
42-102	6375-6385	considered	_
42-103	6386-6388	to	_
42-104	6389-6391	be	_
42-105	6392-6400	outliers	_
42-106	6401-6404	and	_
42-107	6405-6409	were	_
42-108	6410-6418	replaced	_
42-109	6419-6421	by	_
42-110	6422-6425	the	_
42-111	6426-6430	mean	_
42-112	6431-6433	of	_
42-113	6434-6437	the	_
42-114	6438-6441	two	_
42-115	6442-6449	nearest	_
42-116	6450-6459	neighbors	_
42-117	6460-6465	using	_
42-118	6466-6469	the	_
42-119	6470-6478	Analysis	_
42-120	6479-6481	of	_
42-121	6482-6492	Functional	_
42-122	6493-6504	NeuroImages	_
42-123	6505-6506	(	_
42-124	6507-6511	AFNI	_
42-125	6512-6513	)	_
42-126	6514-6522	software	_
42-127	6523-6530	command	_
42-128	6531-6532	“	_
42-129	6533-6542	3dDespike	_
42-130	6543-6544	”	_
42-131	6545-6546	(	_
42-132	6547-6551	http	_
42-133	6552-6553	:	_
42-134	6554-6579	//afni.nimh.nih.gov/afni/	_
42-135	6580-6581	)	_
42-136	6582-6583	.	_

Text=All subsequent preprocessing used Statistical Parametric Mapping 12 (SPM12) software (http: //www.fil.ion.ucl.ac.uk/spm/) implemented in Matlab R2007b (Mathworks Inc. Sherborn MA, USA).
43-1	6584-6587	All	_
43-2	6588-6598	subsequent	_
43-3	6599-6612	preprocessing	_
43-4	6613-6617	used	_
43-5	6618-6629	Statistical	_
43-6	6630-6640	Parametric	_
43-7	6641-6648	Mapping	_
43-8	6649-6651	12	_
43-9	6652-6653	(	_
43-10	6654-6659	SPM12	_
43-11	6660-6661	)	_
43-12	6662-6670	software	_
43-13	6671-6672	(	_
43-14	6673-6677	http	_
43-15	6678-6679	:	_
43-16	6680-6708	//www.fil.ion.ucl.ac.uk/spm/	_
43-17	6709-6710	)	_
43-18	6711-6722	implemented	_
43-19	6723-6725	in	_
43-20	6726-6732	Matlab	_
43-21	6733-6739	R2007b	_
43-22	6740-6741	(	_
43-23	6742-6751	Mathworks	_
43-24	6752-6756	Inc.	_
43-25	6757-6765	Sherborn	_
43-26	6766-6768	MA	_
43-27	6769-6770	,	_
43-28	6771-6774	USA	_
43-29	6775-6776	)	_
43-30	6777-6778	.	_

Text=After slice timing correction, the fMRI series was realigned to the first image to correct for head motion.
44-1	6779-6784	After	_
44-2	6785-6790	slice	_
44-3	6791-6797	timing	_
44-4	6798-6808	correction	_
44-5	6809-6810	,	_
44-6	6811-6814	the	_
44-7	6815-6819	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
44-8	6820-6826	series	_
44-9	6827-6830	was	_
44-10	6831-6840	realigned	_
44-11	6841-6843	to	_
44-12	6844-6847	the	_
44-13	6848-6853	first	_
44-14	6854-6859	image	_
44-15	6860-6862	to	_
44-16	6863-6870	correct	_
44-17	6871-6874	for	_
44-18	6875-6879	head	_
44-19	6880-6886	motion	_
44-20	6887-6888	.	_

Text=Runs with head motion greater than 1 voxel (3.75 mm translation on any axis) or rotation greater than 3.75 degrees were removed from the analysis.
45-1	6889-6893	Runs	_
45-2	6894-6898	with	_
45-3	6899-6903	head	_
45-4	6904-6910	motion	_
45-5	6911-6918	greater	_
45-6	6919-6923	than	_
45-7	6924-6925	1	_
45-8	6926-6931	voxel	_
45-9	6932-6933	(	_
45-10	6934-6938	3.75	_
45-11	6939-6941	mm	_
45-12	6942-6953	translation	_
45-13	6954-6956	on	_
45-14	6957-6960	any	_
45-15	6961-6965	axis	_
45-16	6966-6967	)	_
45-17	6968-6970	or	_
45-18	6971-6979	rotation	_
45-19	6980-6987	greater	_
45-20	6988-6992	than	_
45-21	6993-6997	3.75	_
45-22	6998-7005	degrees	_
45-23	7006-7010	were	_
45-24	7011-7018	removed	_
45-25	7019-7023	from	_
45-26	7024-7027	the	_
45-27	7028-7036	analysis	_
45-28	7037-7038	.	_

Text=The anatomical image was coregistered to the fMRI images and spatially transformed to Montreal Neurological Institute (MNI) standard atlas coordinates using the SPM12 Normalise module with the SPM12 T1 MNI template image.
46-1	7039-7042	The	_
46-2	7043-7053	anatomical	_
46-3	7054-7059	image	_
46-4	7060-7063	was	_
46-5	7064-7076	coregistered	_
46-6	7077-7079	to	_
46-7	7080-7083	the	_
46-8	7084-7088	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
46-9	7089-7095	images	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
46-10	7096-7099	and	_
46-11	7100-7109	spatially	_
46-12	7110-7121	transformed	_
46-13	7122-7124	to	_
46-14	7125-7133	Montreal	_
46-15	7134-7146	Neurological	_
46-16	7147-7156	Institute	_
46-17	7157-7158	(	_
46-18	7159-7162	MNI	_
46-19	7163-7164	)	_
46-20	7165-7173	standard	_
46-21	7174-7179	atlas	_
46-22	7180-7191	coordinates	_
46-23	7192-7197	using	_
46-24	7198-7201	the	_
46-25	7202-7207	SPM12	_
46-26	7208-7217	Normalise	_
46-27	7218-7224	module	_
46-28	7225-7229	with	_
46-29	7230-7233	the	_
46-30	7234-7239	SPM12	_
46-31	7240-7242	T1	_
46-32	7243-7246	MNI	_
46-33	7247-7255	template	_
46-34	7256-7261	image	_
46-35	7262-7263	.	_

Text=The transformation parameters were applied to the fMRI images, which were resliced to 2 mm isotropic resolution and spatially smoothed with a Gaussian filter of 8 mm isotropic full width at half maximum.
47-1	7264-7267	The	_
47-2	7268-7282	transformation	_
47-3	7283-7293	parameters	_
47-4	7294-7298	were	_
47-5	7299-7306	applied	_
47-6	7307-7309	to	_
47-7	7310-7313	the	_
47-8	7314-7318	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
47-9	7319-7325	images	_
47-10	7326-7327	,	_
47-11	7328-7333	which	_
47-12	7334-7338	were	_
47-13	7339-7347	resliced	_
47-14	7348-7350	to	_
47-15	7351-7352	2	_
47-16	7353-7355	mm	_
47-17	7356-7365	isotropic	_
47-18	7366-7376	resolution	_
47-19	7377-7380	and	_
47-20	7381-7390	spatially	_
47-21	7391-7399	smoothed	_
47-22	7400-7404	with	_
47-23	7405-7406	a	_
47-24	7407-7415	Gaussian	_
47-25	7416-7422	filter	_
47-26	7423-7425	of	_
47-27	7426-7427	8	_
47-28	7428-7430	mm	_
47-29	7431-7440	isotropic	_
47-30	7441-7445	full	_
47-31	7446-7451	width	_
47-32	7452-7454	at	_
47-33	7455-7459	half	_
47-34	7460-7467	maximum	_
47-35	7468-7469	.	_

Text=2.5 SPM univariate analysis First level univariate statistical analysis of the fMRI data was conducted using SPM12.
48-1	7470-7473	2.5	_
48-2	7474-7477	SPM	_
48-3	7478-7488	univariate	_
48-4	7489-7497	analysis	_
48-5	7498-7503	First	_
48-6	7504-7509	level	_
48-7	7510-7520	univariate	_
48-8	7521-7532	statistical	_
48-9	7533-7541	analysis	_
48-10	7542-7544	of	_
48-11	7545-7548	the	_
48-12	7549-7553	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
48-13	7554-7558	data	_
48-14	7559-7562	was	_
48-15	7563-7572	conducted	_
48-16	7573-7578	using	_
48-17	7579-7584	SPM12	_
48-18	7585-7586	.	_

Text=CW and NW blocks (conditions) were modeled by boxcar functions convolved with the SPM12 canonical hemodynamic response function.
49-1	7587-7589	CW	_
49-2	7590-7593	and	_
49-3	7594-7596	NW	_
49-4	7597-7603	blocks	_
49-5	7604-7605	(	_
49-6	7606-7616	conditions	_
49-7	7617-7618	)	_
49-8	7619-7623	were	_
49-9	7624-7631	modeled	_
49-10	7632-7634	by	_
49-11	7635-7641	boxcar	_
49-12	7642-7651	functions	_
49-13	7652-7661	convolved	_
49-14	7662-7666	with	_
49-15	7667-7670	the	_
49-16	7671-7676	SPM12	_
49-17	7677-7686	canonical	_
49-18	7687-7698	hemodynamic	_
49-19	7699-7707	response	_
49-20	7708-7716	function	_
49-21	7717-7718	.	_

Text=The parameters for each condition were estimated using the General Linear Model at each voxel without global normalization.
50-1	7719-7722	The	_
50-2	7723-7733	parameters	_
50-3	7734-7737	for	_
50-4	7738-7742	each	_
50-5	7743-7752	condition	_
50-6	7753-7757	were	_
50-7	7758-7767	estimated	_
50-8	7768-7773	using	_
50-9	7774-7777	the	_
50-10	7778-7785	General	_
50-11	7786-7792	Linear	_
50-12	7793-7798	Model	_
50-13	7799-7801	at	_
50-14	7802-7806	each	_
50-15	7807-7812	voxel	_
50-16	7813-7820	without	_
50-17	7821-7827	global	_
50-18	7828-7841	normalization	_
50-19	7842-7843	.	_

Text=The fMRI time series was high-pass filtered with an optimized cut-off period of 188 s determined by the Fourier transformation of each condition ’ s time model.
51-1	7844-7847	The	_
51-2	7848-7852	fMRI	_
51-3	7853-7857	time	_
51-4	7858-7864	series	_
51-5	7865-7868	was	_
51-6	7869-7878	high-pass	_
51-7	7879-7887	filtered	_
51-8	7888-7892	with	_
51-9	7893-7895	an	_
51-10	7896-7905	optimized	_
51-11	7906-7913	cut-off	_
51-12	7914-7920	period	_
51-13	7921-7923	of	_
51-14	7924-7927	188	_
51-15	7928-7929	s	_
51-16	7930-7940	determined	_
51-17	7941-7943	by	_
51-18	7944-7947	the	_
51-19	7948-7955	Fourier	_
51-20	7956-7970	transformation	_
51-21	7971-7973	of	_
51-22	7974-7978	each	_
51-23	7979-7988	condition	_
51-24	7989-7990	’	_
51-25	7991-7992	s	_
51-26	7993-7997	time	_
51-27	7998-8003	model	_
51-28	8004-8005	.	_

Text=Attentional bias activation was defined as the contrast at each voxel of the parameter estimate for CW blocks minus the parameter estimate for NW blocks (CW minus NW contrast).
52-1	8006-8017	Attentional	_
52-2	8018-8022	bias	_
52-3	8023-8033	activation	_
52-4	8034-8037	was	_
52-5	8038-8045	defined	_
52-6	8046-8048	as	_
52-7	8049-8052	the	_
52-8	8053-8061	contrast	_
52-9	8062-8064	at	_
52-10	8065-8069	each	_
52-11	8070-8075	voxel	_
52-12	8076-8078	of	_
52-13	8079-8082	the	_
52-14	8083-8092	parameter	_
52-15	8093-8101	estimate	_
52-16	8102-8105	for	_
52-17	8106-8108	CW	_
52-18	8109-8115	blocks	_
52-19	8116-8121	minus	_
52-20	8122-8125	the	_
52-21	8126-8135	parameter	_
52-22	8136-8144	estimate	_
52-23	8145-8148	for	_
52-24	8149-8151	NW	_
52-25	8152-8158	blocks	_
52-26	8159-8160	(	_
52-27	8161-8163	CW	_
52-28	8164-8169	minus	_
52-29	8170-8172	NW	_
52-30	8173-8181	contrast	_
52-31	8182-8183	)	_
52-32	8184-8185	.	_

Text=The resulting set of voxel values for this contrast constitutes a statistical parametric map for that contrast.
53-1	8186-8189	The	_
53-2	8190-8199	resulting	_
53-3	8200-8203	set	_
53-4	8204-8206	of	_
53-5	8207-8212	voxel	_
53-6	8213-8219	values	_
53-7	8220-8223	for	_
53-8	8224-8228	this	_
53-9	8229-8237	contrast	_
53-10	8238-8249	constitutes	_
53-11	8250-8251	a	_
53-12	8252-8263	statistical	_
53-13	8264-8274	parametric	_
53-14	8275-8278	map	_
53-15	8279-8282	for	_
53-16	8283-8287	that	_
53-17	8288-8296	contrast	_
53-18	8297-8298	.	_

Text=The CW minus NW contrast image (one per subject) was then entered at the SPM12 second level (i.e., random effects) group analysis.
54-1	8299-8302	The	_
54-2	8303-8305	CW	_
54-3	8306-8311	minus	_
54-4	8312-8314	NW	_
54-5	8315-8323	contrast	_
54-6	8324-8329	image	_
54-7	8330-8331	(	_
54-8	8332-8335	one	_
54-9	8336-8339	per	_
54-10	8340-8347	subject	_
54-11	8348-8349	)	_
54-12	8350-8353	was	_
54-13	8354-8358	then	_
54-14	8359-8366	entered	_
54-15	8367-8369	at	_
54-16	8370-8373	the	_
54-17	8374-8379	SPM12	_
54-18	8380-8386	second	_
54-19	8387-8392	level	_
54-20	8393-8394	(	_
54-21	8395-8399	i.e.	_
54-22	8400-8401	,	_
54-23	8402-8408	random	_
54-24	8409-8416	effects	_
54-25	8417-8418	)	_
54-26	8419-8424	group	_
54-27	8425-8433	analysis	_
54-28	8434-8435	.	_

Text=To determine the group level blood-oxygen-level dependent (BOLD) activation, a SPM12 second level Random Effects one-sample t-test was conducted voxel-wise throughout the whole brain for the contrast image (CW minus NW).
55-1	8436-8438	To	_
55-2	8439-8448	determine	_
55-3	8449-8452	the	_
55-4	8453-8458	group	_
55-5	8459-8464	level	_
55-6	8465-8483	blood-oxygen-level	_
55-7	8484-8493	dependent	_
55-8	8494-8495	(	_
55-9	8496-8500	BOLD	_
55-10	8501-8502	)	_
55-11	8503-8513	activation	_
55-12	8514-8515	,	_
55-13	8516-8517	a	_
55-14	8518-8523	SPM12	_
55-15	8524-8530	second	_
55-16	8531-8536	level	_
55-17	8537-8543	Random	_
55-18	8544-8551	Effects	_
55-19	8552-8562	one-sample	_
55-20	8563-8569	t-test	_
55-21	8570-8573	was	_
55-22	8574-8583	conducted	_
55-23	8584-8594	voxel-wise	_
55-24	8595-8605	throughout	_
55-25	8606-8609	the	_
55-26	8610-8615	whole	_
55-27	8616-8621	brain	_
55-28	8622-8625	for	_
55-29	8626-8629	the	_
55-30	8630-8638	contrast	_
55-31	8639-8644	image	_
55-32	8645-8646	(	_
55-33	8647-8649	CW	_
55-34	8650-8655	minus	_
55-35	8656-8658	NW	_
55-36	8659-8660	)	_
55-37	8661-8662	.	_

Text=Statistical significance was defined as family-wise error (FWE) corrected cluster probability (p) less than 0.05 (two tail).
56-1	8663-8674	Statistical	_
56-2	8675-8687	significance	_
56-3	8688-8691	was	_
56-4	8692-8699	defined	_
56-5	8700-8702	as	_
56-6	8703-8714	family-wise	_
56-7	8715-8720	error	_
56-8	8721-8722	(	_
56-9	8723-8726	FWE	_
56-10	8727-8728	)	_
56-11	8729-8738	corrected	_
56-12	8739-8746	cluster	_
56-13	8747-8758	probability	_
56-14	8759-8760	(	_
56-15	8761-8762	p	_
56-16	8763-8764	)	_
56-17	8765-8769	less	_
56-18	8770-8774	than	_
56-19	8775-8779	0.05	_
56-20	8780-8781	(	_
56-21	8782-8785	two	_
56-22	8786-8790	tail	_
56-23	8791-8792	)	_
56-24	8793-8794	.	_

Text=The brain activations found by this analysis were used for DCM nodes (regions of interest) selection, but the statistical significance was defined as uncorrected cluster p less than 0.05 (two tail).
57-1	8795-8798	The	_
57-2	8799-8804	brain	_
57-3	8805-8816	activations	_
57-4	8817-8822	found	_
57-5	8823-8825	by	_
57-6	8826-8830	this	_
57-7	8831-8839	analysis	_
57-8	8840-8844	were	_
57-9	8845-8849	used	_
57-10	8850-8853	for	_
57-11	8854-8857	DCM	_
57-12	8858-8863	nodes	_
57-13	8864-8865	(	_
57-14	8866-8873	regions	_
57-15	8874-8876	of	_
57-16	8877-8885	interest	_
57-17	8886-8887	)	_
57-18	8888-8897	selection	_
57-19	8898-8899	,	_
57-20	8900-8903	but	_
57-21	8904-8907	the	_
57-22	8908-8919	statistical	_
57-23	8920-8932	significance	_
57-24	8933-8936	was	_
57-25	8937-8944	defined	_
57-26	8945-8947	as	_
57-27	8948-8959	uncorrected	_
57-28	8960-8967	cluster	_
57-29	8968-8969	p	_
57-30	8970-8974	less	_
57-31	8975-8979	than	_
57-32	8980-8984	0.05	_
57-33	8985-8986	(	_
57-34	8987-8990	two	_
57-35	8991-8995	tail	_
57-36	8996-8997	)	_
57-37	8998-8999	.	_

Text=It is commonly accepted to use uncorrected cluster p less than 0.05 (two tail) for determining DCM nodes.
58-1	9000-9002	It	_
58-2	9003-9005	is	_
58-3	9006-9014	commonly	_
58-4	9015-9023	accepted	_
58-5	9024-9026	to	_
58-6	9027-9030	use	_
58-7	9031-9042	uncorrected	_
58-8	9043-9050	cluster	_
58-9	9051-9052	p	_
58-10	9053-9057	less	_
58-11	9058-9062	than	_
58-12	9063-9067	0.05	_
58-13	9068-9069	(	_
58-14	9070-9073	two	_
58-15	9074-9078	tail	_
58-16	9079-9080	)	_
58-17	9081-9084	for	_
58-18	9085-9096	determining	_
58-19	9097-9100	DCM	_
58-20	9101-9106	nodes	_
58-21	9107-9108	.	_

Text=For all SPM12 second level analyses, the cluster-defining threshold was t = 2.4.
59-1	9109-9112	For	_
59-2	9113-9116	all	_
59-3	9117-9122	SPM12	_
59-4	9123-9129	second	_
59-5	9130-9135	level	_
59-6	9136-9144	analyses	_
59-7	9145-9146	,	_
59-8	9147-9150	the	_
59-9	9151-9167	cluster-defining	_
59-10	9168-9177	threshold	_
59-11	9178-9181	was	_
59-12	9182-9183	t	_
59-13	9184-9185	=	_
59-14	9186-9189	2.4	_
59-15	9190-9191	.	_

Text=Anatomical labels for regions of activation were determined using the Anatomical Automatic Labeling (AAL) toolbox.
60-1	9192-9202	Anatomical	_
60-2	9203-9209	labels	_
60-3	9210-9213	for	_
60-4	9214-9221	regions	_
60-5	9222-9224	of	_
60-6	9225-9235	activation	_
60-7	9236-9240	were	_
60-8	9241-9251	determined	_
60-9	9252-9257	using	_
60-10	9258-9261	the	_
60-11	9262-9272	Anatomical	_
60-12	9273-9282	Automatic	_
60-13	9283-9291	Labeling	_
60-14	9292-9293	(	_
60-15	9294-9297	AAL	_
60-16	9298-9299	)	_
60-17	9300-9307	toolbox	_
60-18	9308-9309	.	_

Text=2.6 Dynamic causal modeling FMRI-based DCM is a biophysical model of the underlying neuronal connectivity and of how the neuronal connectivity generates the observed BOLD signal.
61-1	9310-9313	2.6	_
61-2	9314-9321	Dynamic	_
61-3	9322-9328	causal	_
61-4	9329-9337	modeling	_
61-5	9338-9348	FMRI-based	_
61-6	9349-9352	DCM	_
61-7	9353-9355	is	_
61-8	9356-9357	a	_
61-9	9358-9369	biophysical	_
61-10	9370-9375	model	_
61-11	9376-9378	of	_
61-12	9379-9382	the	_
61-13	9383-9393	underlying	_
61-14	9394-9402	neuronal	_
61-15	9403-9415	connectivity	_
61-16	9416-9419	and	_
61-17	9420-9422	of	_
61-18	9423-9426	how	_
61-19	9427-9430	the	_
61-20	9431-9439	neuronal	_
61-21	9440-9452	connectivity	_
61-22	9453-9462	generates	_
61-23	9463-9466	the	_
61-24	9467-9475	observed	_
61-25	9476-9480	BOLD	_
61-26	9481-9487	signal	_
61-27	9488-9489	.	_

Text=DCM with stochastic option, as implemented in SPM12 (Revision 6906), was used for effective connectivity analysis.
62-1	9490-9493	DCM	_
62-2	9494-9498	with	_
62-3	9499-9509	stochastic	_
62-4	9510-9516	option	_
62-5	9517-9518	,	_
62-6	9519-9521	as	_
62-7	9522-9533	implemented	_
62-8	9534-9536	in	_
62-9	9537-9542	SPM12	_
62-10	9543-9544	(	_
62-11	9545-9553	Revision	_
62-12	9554-9558	6906	_
62-13	9559-9560	)	_
62-14	9561-9562	,	_
62-15	9563-9566	was	_
62-16	9567-9571	used	_
62-17	9572-9575	for	_
62-18	9576-9585	effective	_
62-19	9586-9598	connectivity	_
62-20	9599-9607	analysis	_
62-21	9608-9609	.	_

Text=DCM has been described elsewhere.
63-1	9610-9613	DCM	_
63-2	9614-9617	has	_
63-3	9618-9622	been	_
63-4	9623-9632	described	_
63-5	9633-9642	elsewhere	_
63-6	9643-9644	.	_

Text=In brief, the mathematical model of the underlying neuronal connectivity among an a priori selected set of brain regions is a system of bilinear differential state equations with coefficients specified by three matrices (A matrix, B matrix and C matrix).
64-1	9645-9647	In	_
64-2	9648-9653	brief	_
64-3	9654-9655	,	_
64-4	9656-9659	the	_
64-5	9660-9672	mathematical	_
64-6	9673-9678	model	_
64-7	9679-9681	of	_
64-8	9682-9685	the	_
64-9	9686-9696	underlying	_
64-10	9697-9705	neuronal	_
64-11	9706-9718	connectivity	_
64-12	9719-9724	among	_
64-13	9725-9727	an	_
64-14	9728-9729	a	_
64-15	9730-9736	priori	_
64-16	9737-9745	selected	_
64-17	9746-9749	set	_
64-18	9750-9752	of	_
64-19	9753-9758	brain	_
64-20	9759-9766	regions	_
64-21	9767-9769	is	_
64-22	9770-9771	a	_
64-23	9772-9778	system	_
64-24	9779-9781	of	_
64-25	9782-9790	bilinear	_
64-26	9791-9803	differential	_
64-27	9804-9809	state	_
64-28	9810-9819	equations	_
64-29	9820-9824	with	_
64-30	9825-9837	coefficients	_
64-31	9838-9847	specified	_
64-32	9848-9850	by	_
64-33	9851-9856	three	_
64-34	9857-9865	matrices	_
64-35	9866-9867	(	_
64-36	9868-9869	A	_
64-37	9870-9876	matrix	_
64-38	9877-9878	,	_
64-39	9879-9880	B	_
64-40	9881-9887	matrix	_
64-41	9888-9891	and	_
64-42	9892-9893	C	_
64-43	9894-9900	matrix	_
64-44	9901-9902	)	_
64-45	9903-9904	.	_

Text=In this model, the experimental conditions (i.e., CW and NW) can serve as inputs to the model as either driving inputs, or modulatory inputs, or both.
65-1	9905-9907	In	_
65-2	9908-9912	this	_
65-3	9913-9918	model	_
65-4	9919-9920	,	_
65-5	9921-9924	the	_
65-6	9925-9937	experimental	_
65-7	9938-9948	conditions	_
65-8	9949-9950	(	_
65-9	9951-9955	i.e.	_
65-10	9956-9957	,	_
65-11	9958-9960	CW	_
65-12	9961-9964	and	_
65-13	9965-9967	NW	_
65-14	9968-9969	)	_
65-15	9970-9973	can	_
65-16	9974-9979	serve	_
65-17	9980-9982	as	_
65-18	9983-9989	inputs	_
65-19	9990-9992	to	_
65-20	9993-9996	the	_
65-21	9997-10002	model	_
65-22	10003-10005	as	_
65-23	10006-10012	either	_
65-24	10013-10020	driving	_
65-25	10021-10027	inputs	_
65-26	10028-10029	,	_
65-27	10030-10032	or	_
65-28	10033-10043	modulatory	_
65-29	10044-10050	inputs	_
65-30	10051-10052	,	_
65-31	10053-10055	or	_
65-32	10056-10060	both	_
65-33	10061-10062	.	_

Text=The DCM analysis determines which particular nodes in the model exhibit effective connectivity with other specific nodes in the model, which nodes receive driving inputs from experimental conditions into the model, and which specific connectivities between nodes in the model are modulated (i.e., changed in connectivity strength, in units of Hz) under experimental conditions.
66-1	10063-10066	The	_
66-2	10067-10070	DCM	_
66-3	10071-10079	analysis	_
66-4	10080-10090	determines	_
66-5	10091-10096	which	_
66-6	10097-10107	particular	_
66-7	10108-10113	nodes	_
66-8	10114-10116	in	_
66-9	10117-10120	the	_
66-10	10121-10126	model	_
66-11	10127-10134	exhibit	_
66-12	10135-10144	effective	_
66-13	10145-10157	connectivity	_
66-14	10158-10162	with	_
66-15	10163-10168	other	_
66-16	10169-10177	specific	_
66-17	10178-10183	nodes	_
66-18	10184-10186	in	_
66-19	10187-10190	the	_
66-20	10191-10196	model	_
66-21	10197-10198	,	_
66-22	10199-10204	which	_
66-23	10205-10210	nodes	_
66-24	10211-10218	receive	_
66-25	10219-10226	driving	_
66-26	10227-10233	inputs	_
66-27	10234-10238	from	_
66-28	10239-10251	experimental	_
66-29	10252-10262	conditions	_
66-30	10263-10267	into	_
66-31	10268-10271	the	_
66-32	10272-10277	model	_
66-33	10278-10279	,	_
66-34	10280-10283	and	_
66-35	10284-10289	which	_
66-36	10290-10298	specific	_
66-37	10299-10313	connectivities	_
66-38	10314-10321	between	_
66-39	10322-10327	nodes	_
66-40	10328-10330	in	_
66-41	10331-10334	the	_
66-42	10335-10340	model	_
66-43	10341-10344	are	_
66-44	10345-10354	modulated	_
66-45	10355-10356	(	_
66-46	10357-10361	i.e.	_
66-47	10362-10363	,	_
66-48	10364-10371	changed	_
66-49	10372-10374	in	_
66-50	10375-10387	connectivity	_
66-51	10388-10396	strength	_
66-52	10397-10398	,	_
66-53	10399-10401	in	_
66-54	10402-10407	units	_
66-55	10408-10410	of	_
66-56	10411-10413	Hz	_
66-57	10414-10415	)	_
66-58	10416-10421	under	_
66-59	10422-10434	experimental	_
66-60	10435-10445	conditions	_
66-61	10446-10447	.	_

Text=A node (driving input location) in the model that receives driving inputs, as quantified by the C matrix parameters, is the brain region among the nodes in the model which first experiences a change in neuronal activity.
67-1	10448-10449	A	_
67-2	10450-10454	node	_
67-3	10455-10456	(	_
67-4	10457-10464	driving	_
67-5	10465-10470	input	_
67-6	10471-10479	location	_
67-7	10480-10481	)	_
67-8	10482-10484	in	_
67-9	10485-10488	the	_
67-10	10489-10494	model	_
67-11	10495-10499	that	_
67-12	10500-10508	receives	_
67-13	10509-10516	driving	_
67-14	10517-10523	inputs	_
67-15	10524-10525	,	_
67-16	10526-10528	as	_
67-17	10529-10539	quantified	_
67-18	10540-10542	by	_
67-19	10543-10546	the	_
67-20	10547-10548	C	_
67-21	10549-10555	matrix	_
67-22	10556-10566	parameters	_
67-23	10567-10568	,	_
67-24	10569-10571	is	_
67-25	10572-10575	the	_
67-26	10576-10581	brain	_
67-27	10582-10588	region	_
67-28	10589-10594	among	_
67-29	10595-10598	the	_
67-30	10599-10604	nodes	_
67-31	10605-10607	in	_
67-32	10608-10611	the	_
67-33	10612-10617	model	_
67-34	10618-10623	which	_
67-35	10624-10629	first	_
67-36	10630-10641	experiences	_
67-37	10642-10643	a	_
67-38	10644-10650	change	_
67-39	10651-10653	in	_
67-40	10654-10662	neuronal	_
67-41	10663-10671	activity	_
67-42	10672-10673	.	_

Text=The node that receives the driving input then influences (“ drives ”) the connectivity to other nodes in the model.
68-1	10674-10677	The	_
68-2	10678-10682	node	_
68-3	10683-10687	that	_
68-4	10688-10696	receives	_
68-5	10697-10700	the	_
68-6	10701-10708	driving	_
68-7	10709-10714	input	_
68-8	10715-10719	then	_
68-9	10720-10730	influences	_
68-10	10731-10732	(	_
68-11	10733-10734	“	_
68-12	10735-10741	drives	_
68-13	10742-10743	”	_
68-14	10744-10745	)	_
68-15	10746-10749	the	_
68-16	10750-10762	connectivity	_
68-17	10763-10765	to	_
68-18	10766-10771	other	_
68-19	10772-10777	nodes	_
68-20	10778-10780	in	_
68-21	10781-10784	the	_
68-22	10785-10790	model	_
68-23	10791-10792	.	_

Text=The endogenous (or fixed) connectivity in DCM is quantified by the A matrix parameters, which measure the effective connectivity strengths (in units of Hz) between nodes, regardless of the moment-to-moment switching on and off of inputs.
69-1	10793-10796	The	_
69-2	10797-10807	endogenous	_
69-3	10808-10809	(	_
69-4	10810-10812	or	_
69-5	10813-10818	fixed	_
69-6	10819-10820	)	_
69-7	10821-10833	connectivity	_
69-8	10834-10836	in	_
69-9	10837-10840	DCM	_
69-10	10841-10843	is	_
69-11	10844-10854	quantified	_
69-12	10855-10857	by	_
69-13	10858-10861	the	_
69-14	10862-10863	A	_
69-15	10864-10870	matrix	_
69-16	10871-10881	parameters	_
69-17	10882-10883	,	_
69-18	10884-10889	which	_
69-19	10890-10897	measure	_
69-20	10898-10901	the	_
69-21	10902-10911	effective	_
69-22	10912-10924	connectivity	_
69-23	10925-10934	strengths	_
69-24	10935-10936	(	_
69-25	10937-10939	in	_
69-26	10940-10945	units	_
69-27	10946-10948	of	_
69-28	10949-10951	Hz	_
69-29	10952-10953	)	_
69-30	10954-10961	between	_
69-31	10962-10967	nodes	_
69-32	10968-10969	,	_
69-33	10970-10980	regardless	_
69-34	10981-10983	of	_
69-35	10984-10987	the	_
69-36	10988-11004	moment-to-moment	_
69-37	11005-11014	switching	_
69-38	11015-11017	on	_
69-39	11018-11021	and	_
69-40	11022-11025	off	_
69-41	11026-11028	of	_
69-42	11029-11035	inputs	_
69-43	11036-11037	.	_

Text=Experimental conditions (CW and NW) can modulate the endogenous connectivity among nodes.
70-1	11038-11050	Experimental	_
70-2	11051-11061	conditions	_
70-3	11062-11063	(	_
70-4	11064-11066	CW	_
70-5	11067-11070	and	_
70-6	11071-11073	NW	_
70-7	11074-11075	)	_
70-8	11076-11079	can	_
70-9	11080-11088	modulate	_
70-10	11089-11092	the	_
70-11	11093-11103	endogenous	_
70-12	11104-11116	connectivity	_
70-13	11117-11122	among	_
70-14	11123-11128	nodes	_
70-15	11129-11130	.	_

Text=These modulation effects are quantified by the B matrix parameters as increased or decreased connectivity strength compared to the endogenous connectivity at different times in the experiment that are related to the timing of changes in the particular experimental conditions.
71-1	11131-11136	These	_
71-2	11137-11147	modulation	_
71-3	11148-11155	effects	_
71-4	11156-11159	are	_
71-5	11160-11170	quantified	_
71-6	11171-11173	by	_
71-7	11174-11177	the	_
71-8	11178-11179	B	_
71-9	11180-11186	matrix	_
71-10	11187-11197	parameters	_
71-11	11198-11200	as	_
71-12	11201-11210	increased	_
71-13	11211-11213	or	_
71-14	11214-11223	decreased	_
71-15	11224-11236	connectivity	_
71-16	11237-11245	strength	_
71-17	11246-11254	compared	_
71-18	11255-11257	to	_
71-19	11258-11261	the	_
71-20	11262-11272	endogenous	_
71-21	11273-11285	connectivity	_
71-22	11286-11288	at	_
71-23	11289-11298	different	_
71-24	11299-11304	times	_
71-25	11305-11307	in	_
71-26	11308-11311	the	_
71-27	11312-11322	experiment	_
71-28	11323-11327	that	_
71-29	11328-11331	are	_
71-30	11332-11339	related	_
71-31	11340-11342	to	_
71-32	11343-11346	the	_
71-33	11347-11353	timing	_
71-34	11354-11356	of	_
71-35	11357-11364	changes	_
71-36	11365-11367	in	_
71-37	11368-11371	the	_
71-38	11372-11382	particular	_
71-39	11383-11395	experimental	_
71-40	11396-11406	conditions	_
71-41	11407-11408	.	_

Text=2.6.1 DCM nodes DCM node selection criteria were: (1) the brain activations found in this study, (2) previous fMRI studies using cocaine stimulus Stroop tasks (e.g.,), and (3) theories about attentional bias (e.g.,).
72-1	11409-11414	2.6.1	_
72-2	11415-11418	DCM	_
72-3	11419-11424	nodes	_
72-4	11425-11428	DCM	_
72-5	11429-11433	node	_
72-6	11434-11443	selection	_
72-7	11444-11452	criteria	_
72-8	11453-11457	were	_
72-9	11458-11459	:	_
72-10	11460-11461	(	_
72-11	11462-11463	1	_
72-12	11464-11465	)	_
72-13	11466-11469	the	_
72-14	11470-11475	brain	_
72-15	11476-11487	activations	_
72-16	11488-11493	found	_
72-17	11494-11496	in	_
72-18	11497-11501	this	_
72-19	11502-11507	study	_
72-20	11508-11509	,	_
72-21	11510-11511	(	_
72-22	11512-11513	2	_
72-23	11514-11515	)	_
72-24	11516-11524	previous	_
72-25	11525-11529	fMRI	_
72-26	11530-11537	studies	_
72-27	11538-11543	using	_
72-28	11544-11551	cocaine	_
72-29	11552-11560	stimulus	_
72-30	11561-11567	Stroop	_
72-31	11568-11573	tasks	_
72-32	11574-11575	(	_
72-33	11576-11580	e.g.	_
72-34	11581-11582	,	_
72-35	11583-11584	)	_
72-36	11585-11586	,	_
72-37	11587-11590	and	_
72-38	11591-11592	(	_
72-39	11593-11594	3	_
72-40	11595-11596	)	_
72-41	11597-11605	theories	_
72-42	11606-11611	about	_
72-43	11612-11623	attentional	_
72-44	11624-11628	bias	_
72-45	11629-11630	(	_
72-46	11631-11635	e.g.	_
72-47	11636-11637	,	_
72-48	11638-11639	)	_
72-49	11640-11641	.	_

Text=Based on meeting the combined presence of all of the above three criteria, the following five regions served as nodes for the DCM analysis: (1) left (L) anterior cingulate cortex (ACC) (x= −8, y=46, z= −4); (2) R ACC (x=10, y=26, z=24); (3) right (R) insula (x=42, y= −10, z= −6); (4) R hippocampus (x=36, y= −18, z= −14); and (5) L caudate (x= −18, y= −8, z=22).
73-1	11642-11647	Based	_
73-2	11648-11650	on	_
73-3	11651-11658	meeting	_
73-4	11659-11662	the	_
73-5	11663-11671	combined	_
73-6	11672-11680	presence	_
73-7	11681-11683	of	_
73-8	11684-11687	all	_
73-9	11688-11690	of	_
73-10	11691-11694	the	_
73-11	11695-11700	above	_
73-12	11701-11706	three	_
73-13	11707-11715	criteria	_
73-14	11716-11717	,	_
73-15	11718-11721	the	_
73-16	11722-11731	following	_
73-17	11732-11736	five	_
73-18	11737-11744	regions	_
73-19	11745-11751	served	_
73-20	11752-11754	as	_
73-21	11755-11760	nodes	_
73-22	11761-11764	for	_
73-23	11765-11768	the	_
73-24	11769-11772	DCM	_
73-25	11773-11781	analysis	_
73-26	11782-11783	:	_
73-27	11784-11785	(	_
73-28	11786-11787	1	_
73-29	11788-11789	)	_
73-30	11790-11794	left	_
73-31	11795-11796	(	_
73-32	11797-11798	L	_
73-33	11799-11800	)	_
73-34	11801-11809	anterior	_
73-35	11810-11819	cingulate	_
73-36	11820-11826	cortex	_
73-37	11827-11828	(	_
73-38	11829-11832	ACC	_
73-39	11833-11834	)	_
73-40	11835-11836	(	_
73-41	11837-11839	x=	_
73-42	11840-11842	−8	_
73-43	11843-11844	,	_
73-44	11845-11849	y=46	_
73-45	11850-11851	,	_
73-46	11852-11854	z=	_
73-47	11855-11857	−4	_
73-48	11858-11859	)	_
73-49	11860-11861	;	_
73-50	11862-11863	(	_
73-51	11864-11865	2	_
73-52	11866-11867	)	_
73-53	11868-11869	R	_
73-54	11870-11873	ACC	_
73-55	11874-11875	(	_
73-56	11876-11880	x=10	_
73-57	11881-11882	,	_
73-58	11883-11887	y=26	_
73-59	11888-11889	,	_
73-60	11890-11894	z=24	_
73-61	11895-11896	)	_
73-62	11897-11898	;	_
73-63	11899-11900	(	_
73-64	11901-11902	3	_
73-65	11903-11904	)	_
73-66	11905-11910	right	_
73-67	11911-11912	(	_
73-68	11913-11914	R	_
73-69	11915-11916	)	_
73-70	11917-11923	insula	_
73-71	11924-11925	(	_
73-72	11926-11930	x=42	_
73-73	11931-11932	,	_
73-74	11933-11935	y=	_
73-75	11936-11939	−10	_
73-76	11940-11941	,	_
73-77	11942-11944	z=	_
73-78	11945-11947	−6	_
73-79	11948-11949	)	_
73-80	11950-11951	;	_
73-81	11952-11953	(	_
73-82	11954-11955	4	_
73-83	11956-11957	)	_
73-84	11958-11959	R	_
73-85	11960-11971	hippocampus	_
73-86	11972-11973	(	_
73-87	11974-11978	x=36	_
73-88	11979-11980	,	_
73-89	11981-11983	y=	_
73-90	11984-11987	−18	_
73-91	11988-11989	,	_
73-92	11990-11992	z=	_
73-93	11993-11996	−14	_
73-94	11997-11998	)	_
73-95	11999-12000	;	_
73-96	12001-12004	and	_
73-97	12005-12006	(	_
73-98	12007-12008	5	_
73-99	12009-12010	)	_
73-100	12011-12012	L	_
73-101	12013-12020	caudate	_
73-102	12021-12022	(	_
73-103	12023-12025	x=	_
73-104	12026-12029	−18	_
73-105	12030-12031	,	_
73-106	12032-12034	y=	_
73-107	12035-12037	−8	_
73-108	12038-12039	,	_
73-109	12040-12044	z=22	_
73-110	12045-12046	)	_
73-111	12047-12048	.	_

Text=The x, y, z values are the MNI coordinates of the center of each node, which were defined as a sphere with 5 mm radius and centered at local maximum of the regional fMRI activation corresponding to that node.
74-1	12049-12052	The	_
74-2	12053-12054	x	_
74-3	12055-12056	,	_
74-4	12057-12058	y	_
74-5	12059-12060	,	_
74-6	12061-12062	z	_
74-7	12063-12069	values	_
74-8	12070-12073	are	_
74-9	12074-12077	the	_
74-10	12078-12081	MNI	_
74-11	12082-12093	coordinates	_
74-12	12094-12096	of	_
74-13	12097-12100	the	_
74-14	12101-12107	center	_
74-15	12108-12110	of	_
74-16	12111-12115	each	_
74-17	12116-12120	node	_
74-18	12121-12122	,	_
74-19	12123-12128	which	_
74-20	12129-12133	were	_
74-21	12134-12141	defined	_
74-22	12142-12144	as	_
74-23	12145-12146	a	_
74-24	12147-12153	sphere	_
74-25	12154-12158	with	_
74-26	12159-12160	5	_
74-27	12161-12163	mm	_
74-28	12164-12170	radius	_
74-29	12171-12174	and	_
74-30	12175-12183	centered	_
74-31	12184-12186	at	_
74-32	12187-12192	local	_
74-33	12193-12200	maximum	_
74-34	12201-12203	of	_
74-35	12204-12207	the	_
74-36	12208-12216	regional	_
74-37	12217-12221	fMRI	_
74-38	12222-12232	activation	_
74-39	12233-12246	corresponding	_
74-40	12247-12249	to	_
74-41	12250-12254	that	_
74-42	12255-12259	node	_
74-43	12260-12261	.	_

Text=For each node, the functional activation BOLD time-series, which was used for DCM analysis, was extracted using the methods described in.
75-1	12262-12265	For	_
75-2	12266-12270	each	_
75-3	12271-12275	node	_
75-4	12276-12277	,	_
75-5	12278-12281	the	_
75-6	12282-12292	functional	_
75-7	12293-12303	activation	_
75-8	12304-12308	BOLD	_
75-9	12309-12320	time-series	_
75-10	12321-12322	,	_
75-11	12323-12328	which	_
75-12	12329-12332	was	_
75-13	12333-12337	used	_
75-14	12338-12341	for	_
75-15	12342-12345	DCM	_
75-16	12346-12354	analysis	_
75-17	12355-12356	,	_
75-18	12357-12360	was	_
75-19	12361-12370	extracted	_
75-20	12371-12376	using	_
75-21	12377-12380	the	_
75-22	12381-12388	methods	_
75-23	12389-12398	described	_
75-24	12399-12401	in	_
75-25	12402-12403	.	_

Text=2.6.2 Driving input and modulatory input The CW and NW experimental conditions were not directly used as inputs.
76-1	12404-12409	2.6.2	_
76-2	12410-12417	Driving	_
76-3	12418-12423	input	_
76-4	12424-12427	and	_
76-5	12428-12438	modulatory	_
76-6	12439-12444	input	_
76-7	12445-12448	The	_
76-8	12449-12451	CW	_
76-9	12452-12455	and	_
76-10	12456-12458	NW	_
76-11	12459-12471	experimental	_
76-12	12472-12482	conditions	_
76-13	12483-12487	were	_
76-14	12488-12491	not	_
76-15	12492-12500	directly	_
76-16	12501-12505	used	_
76-17	12506-12508	as	_
76-18	12509-12515	inputs	_
76-19	12516-12517	.	_

Text=Following and, we created a parametric regressor for “ All Words ” contrast, and another parametric regressor for CW minus NW contrast.
77-1	12518-12527	Following	_
77-2	12528-12531	and	_
77-3	12532-12533	,	_
77-4	12534-12536	we	_
77-5	12537-12544	created	_
77-6	12545-12546	a	_
77-7	12547-12557	parametric	_
77-8	12558-12567	regressor	_
77-9	12568-12571	for	_
77-10	12572-12573	“	_
77-11	12574-12577	All	_
77-12	12578-12583	Words	_
77-13	12584-12585	”	_
77-14	12586-12594	contrast	_
77-15	12595-12596	,	_
77-16	12597-12600	and	_
77-17	12601-12608	another	_
77-18	12609-12619	parametric	_
77-19	12620-12629	regressor	_
77-20	12630-12633	for	_
77-21	12634-12636	CW	_
77-22	12637-12642	minus	_
77-23	12643-12645	NW	_
77-24	12646-12654	contrast	_
77-25	12655-12656	.	_

Text=The method of constructing these regressors can be found online (https: //github.com/HaukeHillebrandt/SPM_connectome).
78-1	12657-12660	The	_
78-2	12661-12667	method	_
78-3	12668-12670	of	_
78-4	12671-12683	constructing	_
78-5	12684-12689	these	_
78-6	12690-12700	regressors	_
78-7	12701-12704	can	_
78-8	12705-12707	be	_
78-9	12708-12713	found	_
78-10	12714-12720	online	_
78-11	12721-12722	(	_
78-12	12723-12728	https	_
78-13	12729-12730	:	_
78-14	12731-12775	//github.com/HaukeHillebrandt/SPM_connectome	_
78-15	12776-12777	)	_
78-16	12778-12779	.	_

Text=The “ All Words ” contrast, which reflects the common features of the CW and NW, was used as a single input to the DCM (driving input).
79-1	12780-12783	The	_
79-2	12784-12785	“	_
79-3	12786-12789	All	_
79-4	12790-12795	Words	_
79-5	12796-12797	”	_
79-6	12798-12806	contrast	_
79-7	12807-12808	,	_
79-8	12809-12814	which	_
79-9	12815-12823	reflects	_
79-10	12824-12827	the	_
79-11	12828-12834	common	_
79-12	12835-12843	features	_
79-13	12844-12846	of	_
79-14	12847-12850	the	_
79-15	12851-12853	CW	_
79-16	12854-12857	and	_
79-17	12858-12860	NW	_
79-18	12861-12862	,	_
79-19	12863-12866	was	_
79-20	12867-12871	used	_
79-21	12872-12874	as	_
79-22	12875-12876	a	_
79-23	12877-12883	single	_
79-24	12884-12889	input	_
79-25	12890-12892	to	_
79-26	12893-12896	the	_
79-27	12897-12900	DCM	_
79-28	12901-12902	(	_
79-29	12903-12910	driving	_
79-30	12911-12916	input	_
79-31	12917-12918	)	_
79-32	12919-12920	.	_

Text=The CW minus NW contrast, which reflects the special effect of CW over NW, was used as a putative modulator (modulatory input) of effective connectivity (the factor causing changes in the effective connectivities).
80-1	12921-12924	The	_
80-2	12925-12927	CW	_
80-3	12928-12933	minus	_
80-4	12934-12936	NW	_
80-5	12937-12945	contrast	_
80-6	12946-12947	,	_
80-7	12948-12953	which	_
80-8	12954-12962	reflects	_
80-9	12963-12966	the	_
80-10	12967-12974	special	_
80-11	12975-12981	effect	_
80-12	12982-12984	of	_
80-13	12985-12987	CW	_
80-14	12988-12992	over	_
80-15	12993-12995	NW	_
80-16	12996-12997	,	_
80-17	12998-13001	was	_
80-18	13002-13006	used	_
80-19	13007-13009	as	_
80-20	13010-13011	a	_
80-21	13012-13020	putative	_
80-22	13021-13030	modulator	_
80-23	13031-13032	(	_
80-24	13033-13043	modulatory	_
80-25	13044-13049	input	_
80-26	13050-13051	)	_
80-27	13052-13054	of	_
80-28	13055-13064	effective	_
80-29	13065-13077	connectivity	_
80-30	13078-13079	(	_
80-31	13080-13083	the	_
80-32	13084-13090	factor	_
80-33	13091-13098	causing	_
80-34	13099-13106	changes	_
80-35	13107-13109	in	_
80-36	13110-13113	the	_
80-37	13114-13123	effective	_
80-38	13124-13138	connectivities	_
80-39	13139-13140	)	_
80-40	13141-13142	.	_

Text=In the present study, the changes of effective connectivities (relative to the endogenous connectivities) caused by the CW minus NW modulator are termed as modulatory changes.
81-1	13143-13145	In	_
81-2	13146-13149	the	_
81-3	13150-13157	present	_
81-4	13158-13163	study	_
81-5	13164-13165	,	_
81-6	13166-13169	the	_
81-7	13170-13177	changes	_
81-8	13178-13180	of	_
81-9	13181-13190	effective	_
81-10	13191-13205	connectivities	_
81-11	13206-13207	(	_
81-12	13208-13216	relative	_
81-13	13217-13219	to	_
81-14	13220-13223	the	_
81-15	13224-13234	endogenous	_
81-16	13235-13249	connectivities	_
81-17	13250-13251	)	_
81-18	13252-13258	caused	_
81-19	13259-13261	by	_
81-20	13262-13265	the	_
81-21	13266-13268	CW	_
81-22	13269-13274	minus	_
81-23	13275-13277	NW	_
81-24	13278-13287	modulator	_
81-25	13288-13291	are	_
81-26	13292-13298	termed	_
81-27	13299-13301	as	_
81-28	13302-13312	modulatory	_
81-29	13313-13320	changes	_
81-30	13321-13322	.	_

Text=By definition, a modulatory change reflects the change in an effective connectivity caused by the CW minus the change in this effective connectivity caused by the NW.
82-1	13323-13325	By	_
82-2	13326-13336	definition	_
82-3	13337-13338	,	_
82-4	13339-13340	a	_
82-5	13341-13351	modulatory	_
82-6	13352-13358	change	_
82-7	13359-13367	reflects	_
82-8	13368-13371	the	_
82-9	13372-13378	change	_
82-10	13379-13381	in	_
82-11	13382-13384	an	_
82-12	13385-13394	effective	_
82-13	13395-13407	connectivity	_
82-14	13408-13414	caused	_
82-15	13415-13417	by	_
82-16	13418-13421	the	_
82-17	13422-13424	CW	_
82-18	13425-13430	minus	_
82-19	13431-13434	the	_
82-20	13435-13441	change	_
82-21	13442-13444	in	_
82-22	13445-13449	this	_
82-23	13450-13459	effective	_
82-24	13460-13472	connectivity	_
82-25	13473-13479	caused	_
82-26	13480-13482	by	_
82-27	13483-13486	the	_
82-28	13487-13489	NW	_
82-29	13490-13491	.	_

Text=Thus the effects of drug cues (CW) on the behavioral performance (reaction time), brain activation, and effective connectivity were all assessed relative to NW in the present study.
83-1	13492-13496	Thus	_
83-2	13497-13500	the	_
83-3	13501-13508	effects	_
83-4	13509-13511	of	_
83-5	13512-13516	drug	_
83-6	13517-13521	cues	_
83-7	13522-13523	(	_
83-8	13524-13526	CW	_
83-9	13527-13528	)	_
83-10	13529-13531	on	_
83-11	13532-13535	the	_
83-12	13536-13546	behavioral	_
83-13	13547-13558	performance	_
83-14	13559-13560	(	_
83-15	13561-13569	reaction	_
83-16	13570-13574	time	_
83-17	13575-13576	)	_
83-18	13577-13578	,	_
83-19	13579-13584	brain	_
83-20	13585-13595	activation	_
83-21	13596-13597	,	_
83-22	13598-13601	and	_
83-23	13602-13611	effective	_
83-24	13612-13624	connectivity	_
83-25	13625-13629	were	_
83-26	13630-13633	all	_
83-27	13634-13642	assessed	_
83-28	13643-13651	relative	_
83-29	13652-13654	to	_
83-30	13655-13657	NW	_
83-31	13658-13660	in	_
83-32	13661-13664	the	_
83-33	13665-13672	present	_
83-34	13673-13678	study	_
83-35	13679-13680	.	_

Text=2.6.3 DCM inference Given the nodes of the model, a DCM post-hoc optimization analysis was used for model structure inference.
84-1	13681-13686	2.6.3	_
84-2	13687-13690	DCM	_
84-3	13691-13700	inference	_
84-4	13701-13706	Given	_
84-5	13707-13710	the	_
84-6	13711-13716	nodes	_
84-7	13717-13719	of	_
84-8	13720-13723	the	_
84-9	13724-13729	model	_
84-10	13730-13731	,	_
84-11	13732-13733	a	_
84-12	13734-13737	DCM	_
84-13	13738-13746	post-hoc	_
84-14	13747-13759	optimization	_
84-15	13760-13768	analysis	_
84-16	13769-13772	was	_
84-17	13773-13777	used	_
84-18	13778-13781	for	_
84-19	13782-13787	model	_
84-20	13788-13797	structure	_
84-21	13798-13807	inference	_
84-22	13808-13809	.	_

Text=Starting from a fully-connected model, the post hoc optimization analysis systematically searches for an optimal “ sparse ” model that determines which particular nodes exhibit effective connectivity with other nodes (i.e., endogenous connectivity), which nodes first experience a change in neuronal activity associated with the “ All Words ” input (i.e., driving input effects), and which effective connectivities showed modulatory changes associated with the CW minus NW modulator.
85-1	13810-13818	Starting	_
85-2	13819-13823	from	_
85-3	13824-13825	a	_
85-4	13826-13841	fully-connected	_
85-5	13842-13847	model	_
85-6	13848-13849	,	_
85-7	13850-13853	the	_
85-8	13854-13858	post	_
85-9	13859-13862	hoc	_
85-10	13863-13875	optimization	_
85-11	13876-13884	analysis	_
85-12	13885-13899	systematically	_
85-13	13900-13908	searches	_
85-14	13909-13912	for	_
85-15	13913-13915	an	_
85-16	13916-13923	optimal	_
85-17	13924-13925	“	_
85-18	13926-13932	sparse	_
85-19	13933-13934	”	_
85-20	13935-13940	model	_
85-21	13941-13945	that	_
85-22	13946-13956	determines	_
85-23	13957-13962	which	_
85-24	13963-13973	particular	_
85-25	13974-13979	nodes	_
85-26	13980-13987	exhibit	_
85-27	13988-13997	effective	_
85-28	13998-14010	connectivity	_
85-29	14011-14015	with	_
85-30	14016-14021	other	_
85-31	14022-14027	nodes	_
85-32	14028-14029	(	_
85-33	14030-14034	i.e.	_
85-34	14035-14036	,	_
85-35	14037-14047	endogenous	_
85-36	14048-14060	connectivity	_
85-37	14061-14062	)	_
85-38	14063-14064	,	_
85-39	14065-14070	which	_
85-40	14071-14076	nodes	_
85-41	14077-14082	first	_
85-42	14083-14093	experience	_
85-43	14094-14095	a	_
85-44	14096-14102	change	_
85-45	14103-14105	in	_
85-46	14106-14114	neuronal	_
85-47	14115-14123	activity	_
85-48	14124-14134	associated	_
85-49	14135-14139	with	_
85-50	14140-14143	the	_
85-51	14144-14145	“	_
85-52	14146-14149	All	_
85-53	14150-14155	Words	_
85-54	14156-14157	”	_
85-55	14158-14163	input	_
85-56	14164-14165	(	_
85-57	14166-14170	i.e.	_
85-58	14171-14172	,	_
85-59	14173-14180	driving	_
85-60	14181-14186	input	_
85-61	14187-14194	effects	_
85-62	14195-14196	)	_
85-63	14197-14198	,	_
85-64	14199-14202	and	_
85-65	14203-14208	which	_
85-66	14209-14218	effective	_
85-67	14219-14233	connectivities	_
85-68	14234-14240	showed	_
85-69	14241-14251	modulatory	_
85-70	14252-14259	changes	_
85-71	14260-14270	associated	_
85-72	14271-14275	with	_
85-73	14276-14279	the	_
85-74	14280-14282	CW	_
85-75	14283-14288	minus	_
85-76	14289-14291	NW	_
85-77	14292-14301	modulator	_
85-78	14302-14303	.	_

Text=Based on the results of the post hoc optimization analysis, a Bayesian model averaging (BMA) analysis was conducted for DCM parameter inference, with a model space consisting of the fully-connected model and the optimal sparse model.
86-1	14304-14309	Based	_
86-2	14310-14312	on	_
86-3	14313-14316	the	_
86-4	14317-14324	results	_
86-5	14325-14327	of	_
86-6	14328-14331	the	_
86-7	14332-14336	post	_
86-8	14337-14340	hoc	_
86-9	14341-14353	optimization	_
86-10	14354-14362	analysis	_
86-11	14363-14364	,	_
86-12	14365-14366	a	_
86-13	14367-14375	Bayesian	_
86-14	14376-14381	model	_
86-15	14382-14391	averaging	_
86-16	14392-14393	(	_
86-17	14394-14397	BMA	_
86-18	14398-14399	)	_
86-19	14400-14408	analysis	_
86-20	14409-14412	was	_
86-21	14413-14422	conducted	_
86-22	14423-14426	for	_
86-23	14427-14430	DCM	_
86-24	14431-14440	parameter	_
86-25	14441-14450	inference	_
86-26	14451-14452	,	_
86-27	14453-14457	with	_
86-28	14458-14459	a	_
86-29	14460-14465	model	_
86-30	14466-14471	space	_
86-31	14472-14482	consisting	_
86-32	14483-14485	of	_
86-33	14486-14489	the	_
86-34	14490-14505	fully-connected	_
86-35	14506-14511	model	_
86-36	14512-14515	and	_
86-37	14516-14519	the	_
86-38	14520-14527	optimal	_
86-39	14528-14534	sparse	_
86-40	14535-14540	model	_
86-41	14541-14542	.	_

Text=BMA averages each DCM parameter across models (and across subjects) such that the contribution of each model (of each subject) for that parameter was weighted by the model ’ s posterior probability.
87-1	14543-14546	BMA	_
87-2	14547-14555	averages	_
87-3	14556-14560	each	_
87-4	14561-14564	DCM	_
87-5	14565-14574	parameter	_
87-6	14575-14581	across	_
87-7	14582-14588	models	_
87-8	14589-14590	(	_
87-9	14591-14594	and	_
87-10	14595-14601	across	_
87-11	14602-14610	subjects	_
87-12	14611-14612	)	_
87-13	14613-14617	such	_
87-14	14618-14622	that	_
87-15	14623-14626	the	_
87-16	14627-14639	contribution	_
87-17	14640-14642	of	_
87-18	14643-14647	each	_
87-19	14648-14653	model	_
87-20	14654-14655	(	_
87-21	14656-14658	of	_
87-22	14659-14663	each	_
87-23	14664-14671	subject	_
87-24	14672-14673	)	_
87-25	14674-14677	for	_
87-26	14678-14682	that	_
87-27	14683-14692	parameter	_
87-28	14693-14696	was	_
87-29	14697-14705	weighted	_
87-30	14706-14708	by	_
87-31	14709-14712	the	_
87-32	14713-14718	model	_
87-33	14719-14720	’	_
87-34	14721-14722	s	_
87-35	14723-14732	posterior	_
87-36	14733-14744	probability	_
87-37	14745-14746	.	_

